Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Bernard Moss

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Anatomy

Chemicals & Drugs

Genes & Molecular Sequences

Concepts & Ideas

Molecular Sequence Data

Physiology

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
59
Earl, Patricia
48
Wyatt, Linda
33
Weisberg, Andrea
22
Wolffe, Elizabeth
20
Robinson, Harriet
20
Senkevich, Tatiana
18
Amara, Rama Rao
17
Fuerst, Thomas
15
Berger, Edward
15
Berzofsky, Jay
13
Montefiori, David
13
Murphy, Brian
12
Flexner, Charles
11
Carroll, MW
10
Americo, Jeffrey

Sign-in to see all Coauthors

Publications

TOP 3
Yang Zhilong; Moss Bernard
Interaction of the vaccinia virus RNA polymerase-associated 94-kilodalton protein with the early transcription factor.
Senkevich Tatiana G; Koonin Eugene V; Moss Bernard
Predicted poxvirus FEN1-like nuclease required for homologous recombination, double-strand break repair and full-size genome formation.
Laliberte Jason P; Moss Bernard
Appraising the apoptotic mimicry model and the role of phospholipids for poxvirus entry.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Bernard Moss (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Yang Zhilong; Moss Bernard
Interaction of the vaccinia virus RNA polymerase-associated 94-kilodalton protein with the early transcription factor.
Journal of virology 2009;83(23):12018-26.
2009: Senkevich Tatiana G; Koonin Eugene V; Moss Bernard
Predicted poxvirus FEN1-like nuclease required for homologous recombination, double-strand break repair and full-size genome formation.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(42):17921-6.
2009: Laliberte Jason P; Moss Bernard
Appraising the apoptotic mimicry model and the role of phospholipids for poxvirus entry.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(41):17517-21.
2009: Earl Patricia L; Cotter Catherine; Moss Bernard; VanCott Thomas; Currier Jeffrey; Eller Leigh Anne; McCutchan Francine; Birx Deborah L; Michael Nelson L; Marovich Mary A; Robb Merlin; Cox Josephine H
Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines.
Vaccine 2009;27(42):5885-95.
2009: Bisht Himani; Weisberg Andrea S; Szajner Patricia; Moss Bernard
Assembly and disassembly of the capsid-like external scaffold of immature virions during vaccinia virus morphogenesis.
Journal of virology 2009;83(18):9140-50.
2009: Satheshkumar P S; Weisberg Andrea; Moss Bernard
Vaccinia virus H7 protein contributes to the formation of crescent membrane precursors of immature virions.
Journal of virology 2009;83(17):8439-50.
2009: Gudmundsdotter Lindvi; Nilsson Charlotta; Brave Andreas; Hejdeman Bo; Earl Patricia; Moss Bernard; Robb Merlin; Cox Josephine; Michael Nelson; Marovich Mary; Biberfeld Gunnel; Sandström Eric; Wahren Britta
Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity.
Vaccine 2009;27(33):4468-74.
2009: Wyatt Linda S; Earl Patricia L; Xiao Wei; Americo Jeffrey L; Cotter Catherine A; Vogt Jennifer; Moss Bernard
Elucidating and minimizing the loss by recombinant vaccinia virus of human immunodeficiency virus gene expression resulting from spontaneous mutations and positive selection.
Journal of virology 2009;83(14):7176-84.
2009: Bengali Zain; Townsley Alan C; Moss Bernard
Vaccinia virus strain differences in cell attachment and entry.
Virology 2009;389(1-2):132-40.
2009: Zhao Jun; Lai Lilin; Amara Rama Rao; Montefiori David C; Villinger Francois; Chennareddi Lakshmi; Wyatt Linda S; Moss Bernard; Robinson Harriet L
Preclinical studies of human immunodeficiency virus/AIDS vaccines: inverse correlation between avidity of anti-Env antibodies and peak postchallenge viremia.
Journal of virology 2009;83(9):4102-11.
2009: Resch Wolfgang; Weisberg Andrea S; Moss Bernard
Expression of the highly conserved vaccinia virus E6 protein is required for virion morphogenesis.
Virology 2009;386(2):478-85.
2009: Satheshkumar P S; Anton Luis C; Sanz Patrick; Moss Bernard
Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes.
Journal of virology 2009;83(6):2469-79.
2009: Schell John; Rose Nina F; Fazo Nicole; Marx Preston A; Hunter Meredith; Ramsburg Elizabeth; Montefiori David; Earl Patricia; Moss Bernard; Rose John K
Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge.
Vaccine 2009;27(7):979-86.
2009: Wagenaar Timothy R; Moss Bernard
Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion.
Journal of virology 2009;83(4):1546-54.
2009: Zhang Leiliang; Lee Stella Y; Beznoussenko Galina V; Peters Peter J; Yang Jia-Shu; Gilbert Hui-ya; Brass Abraham L; Elledge Stephen J; Isaacs Stuart N; Moss Bernard; Mironov Alexander; Hsu Victor W
A role for the host coatomer and KDEL receptor in early vaccinia biogenesis.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(1):163-8.
2009: De Silva Frank S; Paran Nir; Moss Bernard
Products and substrate/template usage of vaccinia virus DNA primase.
Virology 2009;383(1):136-41.
2009: Shinoda Kaori; Wyatt Linda S; Irvine Kari R; Moss Bernard
Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization.
Virology journal 2009;6():28.
2008: Taub Dennis D; Ershler William B; Janowski Mark; Artz Andrew; Key Michael L; McKelvey Julie; Muller Denis; Moss Bernard; Ferrucci Luigi; Duffey Patricia L; Longo Dan L
Immunity from smallpox vaccine persists for decades: a longitudinal study.
The American journal of medicine 2008;121(12):1058-64.
2008: Howard Amanda R; Senkevich Tatiana G; Moss Bernard
Vaccinia virus A26 and A27 proteins form a stable complex tethered to mature virions by association with the A17 transmembrane protein.
Journal of virology 2008;82(24):12384-91.
2008: Sandström Eric; Nilsson Charlotta; Hejdeman Bo; Bråve Andreas; Bratt Göran; Robb Merlin; Cox Josephine; Vancott Thomas; Marovich Mary; Stout Richard; Aboud Said; Bakari Muhammad; Pallangyo Kisali; Ljungberg Karl; Moss Bernard; Earl Patricia; Michael Nelson; Birx Deborah; Mhalu Fred; Wahren Britta; Biberfeld Gunnel;
Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara.
The Journal of infectious diseases 2008;198(10):1482-90.
2008: Belyakov Igor M; Ahlers Jeffrey D; Nabel Gary J; Moss Bernard; Berzofsky Jay A
Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization.
Virology 2008;381(1):106-15.
2008: Satheshkumar P S; Moss Bernard
Poxvirus transcriptome analysis.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(40):E62; author reply E63-4.
2008: Nelson Gretchen E; Sisler Jerry R; Chandran Dev; Moss Bernard
Vaccinia virus entry/fusion complex subunit A28 is a target of neutralizing and protective antibodies.
Virology 2008;380(2):394-401.
2008: Sood Cindy L; Ward Jerrold M; Moss Bernard
Vaccinia virus encodes I5, a small hydrophobic virion membrane protein that enhances replication and virulence in mice.
Journal of virology 2008;82(20):10071-8.
2008: Bisht Himani; Weisberg Andrea S; Moss Bernard
Vaccinia virus l1 protein is required for cell entry and membrane fusion.
Journal of virology 2008;82(17):8687-94.
2008: Earl Patricia L; Americo Jeffrey L; Wyatt Linda S; Espenshade Ondraya; Bassler Jocelyn; Gong Kathy; Lin Shuling; Peters Elizabeth; Rhodes Lowrey; Spano Yvette Edghill; Silvera Peter M; Moss Bernard
Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(31):10889-94.
2008: Fogg Christiana N; Americo Jeffrey L; Earl Patricia L; Resch Wolfgang; Aldaz-Carroll Lydia; Eisenberg Roselyn J; Cohen Gary H; Moss Bernard
Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge.
Journal of virology 2008;82(16):8022-9.
2008: Nelson Gretchen E; Wagenaar Timothy R; Moss Bernard
A conserved sequence within the H2 subunit of the vaccinia virus entry/fusion complex is important for interaction with the A28 subunit and infectivity.
Journal of virology 2008;82(13):6244-50.
2008: Wagenaar Timothy R; Ojeda Suany; Moss Bernard
Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex.
Journal of virology 2008;82(11):5153-60.
2008: Domi Arban; Weisberg Andrea S; Moss Bernard
Vaccinia virus E2L null mutants exhibit a major reduction in extracellular virion formation and virus spread.
Journal of virology 2008;82(9):4215-26.
2008: Senkevich Tatiana G; Wyatt Linda S; Weisberg Andrea S; Koonin Eugene V; Moss Bernard
A conserved poxvirus NlpC/P60 superfamily protein contributes to vaccinia virus virulence in mice but not to replication in cell culture.
Virology 2008;374(2):506-14.
2008: Wyatt Linda S; Belyakov Igor M; Earl Patricia L; Berzofsky Jay A; Moss Bernard
Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA.
Virology 2008;372(2):260-72.
2008: Wyatt Linda S; Earl Patricia L; Vogt Jennifer; Eller Leigh Anne; Chandran Dev; Liu Jinyan; Robinson Harriet L; Moss Bernard
Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines.
Vaccine 2008;26(4):486-93.
2008: Davies D Huw; Wyatt Linda S; Newman Frances K; Earl Patricia L; Chun Sookhee; Hernandez Jenny E; Molina Douglas M; Hirst Siddiqua; Moss Bernard; Frey Sharon E; Felgner Philip L
Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax.
Journal of virology 2008;82(2):652-63.
2008: De Silva Frank S; Moss Bernard
Effects of vaccinia virus uracil DNA glycosylase catalytic site and deoxyuridine triphosphatase deletion mutations individually and together on replication in active and quiescent cells and pathogenesis in mice.
Virology journal 2008;5():145.
2007: Robinson Harriet L; Sharma Sunita; Zhao Jun; Kannanganat Sunil; Lai Lilin; Chennareddi Lakshmi; Yu Tianwei; Montefiori David C; Amara Rama Rao; Wyatt Linda S; Moss Bernard
Immunogenicity in macaques of the clinical product for a clade B DNA/MVA HIV vaccine: elicitation of IFN-gamma, IL-2, and TNF-alpha coproducing CD4 and CD8 T cells.
AIDS research and human retroviruses 2007;23(12):1555-62.
2007: Hebben Matthias; Brants Jan; Birck Catherine; Samama Jean-Pierre; Wasylyk Bohdan; Spehner Danièle; Pradeau Karine; Domi Arban; Moss Bernard; Schultz Patrick; Drillien Robert
High level protein expression in mammalian cells using a safe viral vector: modified vaccinia virus Ankara.
Protein expression and purification 2007;56(2):269-78.
2007: Parrish Susan; Moss Bernard
Characterization of a second vaccinia virus mRNA-decapping enzyme conserved in poxviruses.
Journal of virology 2007;81(23):12973-8.
2007: Lai Lilin; Vödrös Dalma; Kozlowski Pamela A; Montefiori David C; Wilson Robert L; Akerstrom Vicki L; Chennareddi Lakshmi; Yu Tianwei; Kannanganat Sunil; Ofielu Lazarus; Villinger Francois; Wyatt Linda S; Moss Bernard; Amara Rama Rao; Robinson Harriet L
GM-CSF DNA: an adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccine.
Virology 2007;369(1):153-67.
2007: De Silva Frank S; Lewis Whitney; Berglund Peter; Koonin Eugene V; Moss Bernard
Poxvirus DNA primase.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(47):18724-9.
2007: Katsafanas George C; Moss Bernard
Colocalization of transcription and translation within cytoplasmic poxvirus factories coordinates viral expression and subjugates host functions.
Cell host & microbe 2007;2(4):221-8.
2007: Kwissa Marcin; Amara Rama R; Robinson Harriet L; Moss Bernard; Alkan Sefik; Jabbar Abdul; Villinger Francois; Pulendran Bali
Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus.
The Journal of experimental medicine 2007;204(11):2733-46.
2007: Chen Zhaochun; Earl Patricia; Americo Jeffrey; Damon Inger; Smith Scott K; Yu Fujuan; Sebrell Andrew; Emerson Suzanne; Cohen Gary; Eisenberg Roselyn J; Gorshkova Inna; Schuck Peter; Satterfield William; Moss Bernard; Purcell Robert
Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model.
Journal of virology 2007;81(17):8989-95.
2007: Bråve Andreas; Boberg Andreas; Gudmundsdotter Lindvi; Rollman Erik; Hallermalm Kristian; Ljungberg Karl; Blomberg Pontus; Stout Richard; Paulie Staffan; Sandström Eric; Biberfeld Gunnel; Earl Patricia; Moss Bernard; Cox Josephine H; Wahren Britta
A new multi-clade DNA prime/recombinant MVA boost vaccine induces broad and high levels of HIV-1-specific CD8(+) T-cell and humoral responses in mice.
Molecular therapy : the journal of the American Society of Gene Therapy 2007;15(9):1724-33.
2007: Husain Matloob; Weisberg Andrea S; Moss Bernard
Resistance of a vaccinia virus A34R deletion mutant to spontaneous rupture of the outer membrane of progeny virions on the surface of infected cells.
Virology 2007;366(2):424-32.
2007: Nigam Pragati; Earl Patricia L; Americo Jeffrey L; Sharma Sunita; Wyatt Linda S; Edghill-Spano Yvette; Chennareddi Lakshmi S; Silvera Peter; Moss Bernard; Robinson Harriet L; Amara Rama Rao
DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge.
Virology 2007;366(1):73-83.
2007: Earl Patricia L; Americo Jeffrey L; Wyatt Linda S; Eller Leigh Anne; Montefiori David C; Byrum Russ; Piatak Michael; Lifson Jeffrey D; Amara Rama Rao; Robinson Harriet L; Huggins John W; Moss Bernard
Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate.
Virology 2007;366(1):84-97.
2007: Townsley Alan C; Moss Bernard
Two distinct low-pH steps promote entry of vaccinia virus.
Journal of virology 2007;81(16):8613-20.
2007: Wagenaar Timothy R; Moss Bernard
Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex.
Journal of virology 2007;81(12):6286-93.
2007: Liu Jinyan; Hellerstein Michael; McDonnel Michael; Amara Rama Rao; Wyatt Linda S; Moss Bernard; Robinson Harriet L
Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost.
Vaccine 2007;25(15):2951-8.
2007: Fogg Christiana N; Americo Jeffrey L; Lustig Shlomo; Huggins John W; Smith Scott K; Damon Inger; Resch Wolfgang; Earl Patricia L; Klinman Dennis M; Moss Bernard
Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges.
Vaccine 2007;25(15):2787-99.
2007: Husain Matloob; Weisberg Andrea S; Moss Bernard
Sequence-independent targeting of transmembrane proteins synthesized within vaccinia virus factories to nascent viral membranes.
Journal of virology 2007;81(6):2646-55.
2007: Charity James C; Katz Ehud; Moss Bernard
Amino acid substitutions at multiple sites within the vaccinia virus D13 scaffold protein confer resistance to rifampicin.
Virology 2007;359(1):227-32.
2007: Parrish Susan; Resch Wolfgang; Moss Bernard
Vaccinia virus D10 protein has mRNA decapping activity, providing a mechanism for control of host and viral gene expression.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(7):2139-44.
2007: Resch Wolfgang; Hixson Kim K; Moore Ronald J; Lipton Mary S; Moss Bernard
Protein composition of the vaccinia virus mature virion.
Virology 2007;358(1):233-47.
2006: Husain Matloob; Weisberg Andrea S; Moss Bernard
Existence of an operative pathway from the endoplasmic reticulum to the immature poxvirus membrane.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(51):19506-11.
2006: Ojeda Suany; Domi Arban; Moss Bernard
Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complex.
Journal of virology 2006;80(19):9822-30.
2006: Brown Erica; Senkevich Tatiana G; Moss Bernard
Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related L1 protein.
Journal of virology 2006;80(19):9455-64.
2006: Townsley Alan C; Weisberg Andrea S; Wagenaar Timothy R; Moss Bernard
Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway.
Journal of virology 2006;80(18):8899-908.
2006: Robinson Harriet L; Montefiori David C; Villinger Francois; Robinson James E; Sharma Sunita; Wyatt Linda S; Earl Patricia L; McClure Harold M; Moss Bernard; Amara Rama Rao
Studies on GM-CSF DNA as an adjuvant for neutralizing Ab elicited by a DNA/MVA immunodeficiency virus vaccine.
Virology 2006;352(2):285-94.
2006: Ellenberger Dennis; Otten Ronald A; Li Bin; Aidoo Michael; Rodriguez I Vanessa; Sariol Carlos A; Martinez Melween; Monsour Michael; Wyatt Linda; Hudgens Michael G; Kraiselburd Edmundo; Moss Bernard; Robinson Harriet; Folks Thomas; Butera Salvatore
HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges.
Virology 2006;352(1):216-25.
2006: Garcia Alonzo D; Otero Joel; Lebowitz Jacob; Schuck Peter; Moss Bernard
Quaternary structure and cleavage specificity of a poxvirus holliday junction resolvase.
The Journal of biological chemistry 2006;281(17):11618-26.
2006: Liu Jinyan; Wyatt Linda S; Amara Rama Rao; Moss Bernard; Robinson Harriet L
Studies on in vitro expression and in vivo immunogenicity of a recombinant MVA HIV vaccine.
Vaccine 2006;24(16):3332-9.
2006: Chen Zhaochun; Earl Patricia; Americo Jeffrey; Damon Inger; Smith Scott K; Zhou Yi-Hua; Yu Fujuan; Sebrell Andrew; Emerson Suzanne; Cohen Gary; Eisenberg Roselyn J; Svitel Juraj; Schuck Peter; Satterfield William; Moss Bernard; Purcell Robert
Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(6):1882-7.
2006: Naik Arpana M; Chalikonda Sricharan; McCart J Andrea; Xu Hui; Guo Z Sheng; Langham Gregory; Gardner Donald; Mocellin Simone; Lokshin Anna E; Moss Bernard; Alexander H Richard; Bartlett David L
Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primates.
Human gene therapy 2006;17(1):31-45.
2006: Parrish Susan; Moss Bernard
Characterization of a vaccinia virus mutant with a deletion of the D10R gene encoding a putative negative regulator of gene expression.
Journal of virology 2006;80(2):553-61.
2006: Moss Bernard
Poxvirus entry and membrane fusion.
Virology 2006;344(1):48-54.
2006: Ojeda Suany; Senkevich Tatiana G; Moss Bernard
Entry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene.
Journal of virology 2006;80(1):51-61.
2006: de Waal Leon; Süzer Yasemin; Wyatt Linda S; Sintnicolaas Kees; Sutter Gerd; Moss Bernard; Osterhaus Albert D M E; de Swart Rik L
T cell responses to respiratory syncytial virus fusion and attachment proteins in human peripheral blood mononuclear cells.
Viral immunology 2006;19(4):669-78.
2005: Senkevich Tatiana G; Ojeda Suany; Townsley Alan; Nelson Gretchen E; Moss Bernard
Poxvirus multiprotein entry-fusion complex.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(51):18572-7.
2005: Resch Wolfgang; Moss Bernard
The conserved poxvirus L3 virion protein is required for transcription of vaccinia virus early genes.
Journal of virology 2005;79(23):14719-29.
2005: Guo Z Sheng; Naik Arpana; O'Malley Mark E; Popovic Petar; Demarco Richard; Hu Yun; Yin Xiaoyu; Yang Shuting; Zeh Herbert J; Moss Bernard; Lotze Michael T; Bartlett David L
The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2.
Cancer research 2005;65(21):9991-8.
2005: Lustig Shlomo; Fogg Christiana; Whitbeck J Charles; Eisenberg Roselyn J; Cohen Gary H; Moss Bernard
Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge.
Journal of virology 2005;79(21):13454-62.
2005: Aldaz-Carroll Lydia; Whitbeck J Charles; Ponce de Leon Manuel; Lou Huan; Pannell Lewis K; Lebowitz Jacob; Fogg Christiana; White Christine L; Moss Bernard; Cohen Gary H; Eisenberg Roselyn J
Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene.
Virology 2005;341(1):59-71.
2005: Szajner Patricia; Weisberg Andrea S; Lebowitz Jacob; Heuser John; Moss Bernard
External scaffold of spherical immature poxvirus particles is made of protein trimers, forming a honeycomb lattice.
The Journal of cell biology 2005;170(6):971-81.
2005: Townsley Alan C; Senkevich Tatiana G; Moss Bernard
The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion.
Journal of virology 2005;79(17):10988-98.
2005: Ellenberger Dennis; Wyatt Linda; Li Bin; Buge Suzan; Lanier Nattawan; Rodriguez I Vanesssa; Sariol Carlos A; Martinez Melween; Monsour Michael; Vogt Jennifer; Smith James; Otten Ronald; Montefiori David; Kraiselburd Edmundo; Moss Bernard; Robinson Harriet; McNicholl Janet; Butera Salvatore
Comparative immunogenicity in rhesus monkeys of multi-protein HIV-1 (CRF02_AG) DNA/MVA vaccines expressing mature and immature VLPs.
Virology 2005;340(1):21-32.
2005: Townsley Alan C; Senkevich Tatiana G; Moss Bernard
Vaccinia virus A21 virion membrane protein is required for cell entry and fusion.
Journal of virology 2005;79(15):9458-69.
2005: Chiu Wen-Ling; Szajner Patricia; Moss Bernard; Chang Wen
Effects of a temperature sensitivity mutation in the J1R protein component of a complex required for vaccinia virus assembly.
Journal of virology 2005;79(13):8046-56.
2005: Resch Wolfgang; Weisberg Andrea S; Moss Bernard
Vaccinia virus nonstructural protein encoded by the A11R gene is required for formation of the virion membrane.
Journal of virology 2005;79(11):6598-609.
2005: Aldaz-Carroll Lydia; Whitbeck J Charles; Ponce de Leon Manuel; Lou Huan; Hirao Lauren; Isaacs Stuart N; Moss Bernard; Eisenberg Roselyn J; Cohen Gary H
Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.
Journal of virology 2005;79(10):6260-71.
2005: Senkevich Tatiana G; Moss Bernard
Vaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell-cell fusion.
Journal of virology 2005;79(8):4744-54.
2005: Bisht Himani; Roberts Anjeanette; Vogel Leatrice; Subbarao Kanta; Moss Bernard
Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein.
Virology 2005;334(2):160-5.
2005: Husain Matloob; Moss Bernard
Role of receptor-mediated endocytosis in the formation of vaccinia virus extracellular enveloped particles.
Journal of virology 2005;79(7):4080-9.
2005: Su Hua-Poo; Garman Scott C; Allison Timothy J; Fogg Christiana; Moss Bernard; Garboczi David N
The 1.51-Angstrom structure of the poxvirus L1 protein, a target of potent neutralizing antibodies.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(12):4240-5.
2005: Sadagopal Shanmugalakshmi; Amara Rama Rao; Montefiori David C; Wyatt Linda S; Staprans Silvija I; Kozyr Natalia L; McClure Harold M; Moss Bernard; Robinson Harriet L
Signature for long-term vaccine-mediated control of a Simian and human immunodeficiency virus 89.6P challenge: stable low-breadth and low-frequency T-cell response capable of coproducing gamma interferon and interleukin-2.
Journal of virology 2005;79(6):3243-53.
2005: Domi Arban; Moss Bernard
Engineering of a vaccinia virus bacterial artificial chromosome in Escherichia coli by bacteriophage lambda-based recombination.
Nature methods 2005;2(2):95-7.
2005: Smith James M; Amara Rama Rao; Wyatt Linda S; Ellenberger Dennis L; Li Bin; Herndon James G; Patel Milloni; Sharma Sunita; Chennareddi Lakshmi; Butera Sal; McNicholl Janet; McClure Harold M; Moss Bernard; Robinson Harriet L
Studies in macaques on cross-clade T cell responses elicited by a DNA/MVA AIDS vaccine, better conservation of CD8 than CD4 T cell responses.
AIDS research and human retroviruses 2005;21(2):140-4.
2005: Van Rompay Koen K A; Abel Kristina; Lawson Jonathan R; Singh Raman P; Schmidt Kimberli A; Evans Thomas; Earl Patricia; Harvey Danielle; Franchini Genoveffa; Tartaglia James; Montefiori David; Hattangadi Shilpa; Moss Bernard; Marthas Marta L
Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV.
Journal of acquired immune deficiency syndromes (1999) 2005;38(2):124-34.
2005: De Silva Frank S; Moss Bernard
Origin-independent plasmid replication occurs in vaccinia virus cytoplasmic factories and requires all five known poxvirus replication factors.
Virology journal 2005;2():23.
2005: Greenier Jennifer L; Van Rompay Koen K A; Montefiori David; Earl Patricia; Moss Bernard; Marthas Marta L
Simian immunodeficiency virus (SIV) envelope quasispecies transmission and evolution in infant rhesus macaques after oral challenge with uncloned SIVmac251: increased diversity is associated with neutralizing antibodies and improved survival in previously immunized animals.
Virology journal 2005;2():11.
2004: Smith James M; Amara Rama Rao; Campbell David; Xu Yan; Patel Milloni; Sharma Sunita; Butera Salvatore T; Ellenberger Dennis L; Yi Hong; Chennareddi Lakshmi; Herndon James G; Wyatt Linda S; Montefiori David; Moss Bernard; McClure Harold M; Robinson Harriet L
DNA/MVA vaccine for HIV type 1: effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime.
AIDS research and human retroviruses 2004;20(12):1335-47.
2004: Szajner Patricia; Jaffe Howard; Weisberg Andrea S; Moss Bernard
A complex of seven vaccinia virus proteins conserved in all chordopoxviruses is required for the association of membranes and viroplasm to form immature virions.
Virology 2004;330(2):447-59.
2004: Katsafanas George C; Moss Bernard
Vaccinia virus intermediate stage transcription is complemented by Ras-GTPase-activating protein SH3 domain-binding protein (G3BP) and cytoplasmic activation/proliferation-associated protein (p137) individually or as a heterodimer.
The Journal of biological chemistry 2004;279(50):52210-7.
2004: Lustig Shlomo; Fogg Christiana; Whitbeck J Charles; Moss Bernard
Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement.
Virology 2004;328(1):30-5.
2004: da Fonseca Flavio G; Weisberg Andrea S; Caeiro Maria F; Moss Bernard
Vaccinia virus mutants with alanine substitutions in the conserved G5R gene fail to initiate morphogenesis at the nonpermissive temperature.
Journal of virology 2004;78(19):10238-48.
2004: Fogg Christiana; Lustig Shlomo; Whitbeck J Charles; Eisenberg Roselyn J; Cohen Gary H; Moss Bernard
Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions.
Journal of virology 2004;78(19):10230-7.
2004: Puaux Anne-Laure; Marsac Delphine; Prost Stéphane; Singh Mandal K; Earl Patricia; Moss Bernard; Le Grand Roger; Riviere Yves; Michel Marie-Louise
Efficient priming of simian/human immunodeficiency virus (SHIV)-specific T-cell responses with DNA encoding hybrid SHIV/hepatitis B surface antigen particles.
Vaccine 2004;22(27-28):3535-45.
2004: Harrison Stephen C; Alberts Bruce; Ehrenfeld Ellie; Enquist Lynn; Fineberg Harvey; McKnight Steven L; Moss Bernard; O'Donnell Michael; Ploegh Hidde; Schmid Sandra L; Walter K Peter; Theriot Julie
Discovery of antivirals against smallpox.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(31):11178-92.
2004: Ansarah-Sobrinho Camilo; Moss Bernard
Vaccinia virus G1 protein, a predicted metalloprotease, is essential for morphogenesis of infectious virions but not for cleavage of major core proteins.
Journal of virology 2004;78(13):6855-63.
2004: Smith James M; Amara Rama Rao; McClure Harold M; Patel Milloni; Sharma Sunita; Yi Hong; Chennareddi Lakshmi; Herndon James G; Butera Salvatore T; Heneine Walid; Ellenberger Dennis L; Parekh Bharat; Earl Patricia L; Wyatt Linda S; Moss Bernard; Robinson Harriet L
Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in Macaques.
AIDS research and human retroviruses 2004;20(6):654-65.
2004: Wyatt Linda S; Earl Patricia L; Liu Jin Yan; Smith James M; Montefiori David C; Robinson Harriet L; Moss Bernard
Multiprotein HIV type 1 clade B DNA and MVA vaccines: construction, expression, and immunogenicity in rodents of the MVA component.
AIDS research and human retroviruses 2004;20(6):645-53.
2004: Ansarah-Sobrinho Camilo; Moss Bernard
Role of the I7 protein in proteolytic processing of vaccinia virus membrane and core components.
Journal of virology 2004;78(12):6335-43.
2004: Bisht Himani; Roberts Anjeanette; Vogel Leatrice; Bukreyev Alexander; Collins Peter L; Murphy Brian R; Subbarao Kanta; Moss Bernard
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(17):6641-6.
2004: Ramsburg Elizabeth; Rose Nina F; Marx Preston A; Mefford Megan; Nixon Douglas F; Moretto Walter J; Montefiori David; Earl Patricia; Moss Bernard; Rose John K
Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol.
Journal of virology 2004;78(8):3930-40.
2004: Wyatt Linda S; Earl Patricia L; Eller Leigh Anne; Moss Bernard
Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(13):4590-5.
2004: Earl Patricia L; Americo Jeffrey L; Wyatt Linda S; Eller Leigh Anne; Whitbeck J Charles; Cohen Gary H; Eisenberg Roselyn J; Hartmann Christopher J; Jackson David L; Kulesh David A; Martinez Mark J; Miller David M; Mucker Eric M; Shamblin Joshua D; Zwiers Susan H; Huggins John W; Jahrling Peter B; Moss Bernard
Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.
Nature 2004;428(6979):182-5.
2004: Ward Brian M; Moss Bernard
Vaccinia virus A36R membrane protein provides a direct link between intracellular enveloped virions and the microtubule motor kinesin.
Journal of virology 2004;78(5):2486-93.
2004: Senkevich Tatiana G; Ward Brian M; Moss Bernard
Vaccinia virus entry into cells is dependent on a virion surface protein encoded by the A28L gene.
Journal of virology 2004;78(5):2357-66.
2004: Senkevich Tatiana G; Ward Brian M; Moss Bernard
Vaccinia virus A28L gene encodes an essential protein component of the virion membrane with intramolecular disulfide bonds formed by the viral cytoplasmic redox pathway.
Journal of virology 2004;78(5):2348-56.
2004: Center Rob J; Lebowitz Jacob; Leapman Richard D; Moss Bernard
Promoting trimerization of soluble human immunodeficiency virus type 1 (HIV-1) Env through the use of HIV-1/simian immunodeficiency virus chimeras.
Journal of virology 2004;78(5):2265-76.
2004: de Waal Leon; Wyatt Linda S; Yüksel Selma; van Amerongen Geert; Moss Bernard; Niesters Hubert G M; Osterhaus Albert D M E; de Swart Rik L
Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology.
Vaccine 2004;22(8):923-6.
2004: Szajner Patricia; Weisberg Andrea S; Moss Bernard
Physical and functional interactions between vaccinia virus F10 protein kinase and virion assembly proteins A30 and G7.
Journal of virology 2004;78(1):266-74.
2004: Szajner Patricia; Weisberg Andrea S; Moss Bernard
Evidence for an essential catalytic role of the F10 protein kinase in vaccinia virus morphogenesis.
Journal of virology 2004;78(1):257-65.
2003: Chan Francis Ka-Ming; Shisler Joanna; Bixby Jacqueline G; Felices Martin; Zheng Lixin; Appel Michael; Orenstein Jan; Moss Bernard; Lenardo Michael J
A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses.
The Journal of biological chemistry 2003;278(51):51613-21.
2003: Katz Ehud; Ward Brian M; Weisberg Andrea S; Moss Bernard
Mutations in the vaccinia virus A33R and B5R envelope proteins that enhance release of extracellular virions and eliminate formation of actin-containing microvilli without preventing tyrosine phosphorylation of the A36R protein.
Journal of virology 2003;77(22):12266-75.
2003: Husain Matloob; Moss Bernard
Evidence against an essential role of COPII-mediated cargo transport to the endoplasmic reticulum-Golgi intermediate compartment in the formation of the primary membrane of vaccinia virus.
Journal of virology 2003;77(21):11754-66.
2003: Buge Suzan L; Ma Hak-Ling; Amara Rama R; Wyatt Linda S; Earl Patricia L; Villinger François; Montefiori David C; Staprans Silvija I; Xu Yan; Carter Eddye; O'Neil Shawn P; Herndon James G; Hill Elizabeth; Moss Bernard; Robinson Harriet L; McNicholl Janet M
Gp120-alum boosting of a Gag-Pol-Env DNA/MVA AIDS vaccine: poorer control of a pathogenic viral challenge.
AIDS research and human retroviruses 2003;19(10):891-900.
2003: Edghill-Smith Yvette; Venzon David; Karpova Tatiana; McNally James; Nacsa Janos; Tsai Wen-Po; Tryniszewska Elzbieta; Moniuszko Marcin; Manischewitz Jody; King Lisa R; Snodgrass Steven J; Parrish John; Markham Phil; Sowers Marsha; Martin Derrick; Lewis Mark G; Berzofsky Jay A; Belyakov Igor M; Moss Bernard; Tartaglia Jim; Bray Mike; Hirsch Vanessa; Golding Hana; Franchini Genoveffa
Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques.
The Journal of infectious diseases 2003;188(8):1181-91.
2003: Earl Patricia L; Americo Jeffrey L; Moss Bernard
Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein.
Journal of virology 2003;77(19):10684-8.
2003: Da Fonseca Flavio; Moss Bernard
Poxvirus DNA topoisomerase knockout mutant exhibits decreased infectivity associated with reduced early transcription.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(20):11291-6.
2003: Husain Matloob; Moss Bernard
Intracellular trafficking of a palmitoylated membrane-associated protein component of enveloped vaccinia virus.
Journal of virology 2003;77(16):9008-19.
2003: Belyakov Igor M; Earl Patricia; Dzutsev Amiran; Kuznetsov Vladimir A; Lemon Michael; Wyatt Linda S; Snyder James T; Ahlers Jeffrey D; Franchini Genoveffa; Moss Bernard; Berzofsky Jay A
Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(16):9458-63.
2003: Husain Matloob; Weisberg Andrea; Moss Bernard
Topology of epitope-tagged F13L protein, a major membrane component of extracellular vaccinia virions.
Virology 2003;308(2):233-42.
2003: Ward Brian M; Weisberg Andrea S; Moss Bernard
Mapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteins.
Journal of virology 2003;77(7):4113-26.
2003: Szajner Patricia; Jaffe Howard; Weisberg Andrea S; Moss Bernard
Vaccinia virus G7L protein Interacts with the A30L protein and is required for association of viral membranes with dense viroplasm to form immature virions.
Journal of virology 2003;77(6):3418-29.
2003: Xiang Yan; Moss Bernard
Molluscum contagiosum virus interleukin-18 (IL-18) binding protein is secreted as a full-length form that binds cell surface glycosaminoglycans through the C-terminal tail and a furin-cleaved form with only the IL-18 binding domain.
Journal of virology 2003;77(4):2623-30.
2003: Yang Zhi-yong; Wyatt Linda S; Kong Wing-Pui; Moodie Zoe; Moss Bernard; Nabel Gary J
Overcoming immunity to a viral vaccine by DNA priming before vector boosting.
Journal of virology 2003;77(1):799-803.
2003: Van Rompay Koen K A; Greenier Jennifer L; Cole Kelly Stefano; Earl Patricia; Moss Bernard; Steckbeck Jonathan D; Pahar Bapi; Rourke Tracy; Montelaro Ronald C; Canfield Don R; Tarara Ross P; Miller Christopher; McChesney Michael B; Marthas Marta L
Immunization of newborn rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251.
Journal of virology 2003;77(1):179-90.
2003: De Silva Frank S; Moss Bernard
Vaccinia virus uracil DNA glycosylase has an essential role in DNA synthesis that is independent of its glycosylase activity: catalytic site mutations reduce virulence but not virus replication in cultured cells.
Journal of virology 2003;77(1):159-66.
2002: Moss Bernard; Earl Patricia L
Overview of the vaccinia virus expression system.
Current protocols in molecular biology / edited by Frederick M. Ausubel ... [et al.] 2002;Chapter 16():Unit16.15.
2002: Ishii Koji; Moss Bernard
Mapping interaction sites of the A20R protein component of the vaccinia virus DNA replication complex.
Virology 2002;303(2):232-9.
2002: Katz Ehud; Wolffe Elizabeth; Moss Bernard
Identification of second-site mutations that enhance release and spread of vaccinia virus.
Journal of virology 2002;76(22):11637-44.
2002: Baig Jamal; Levy Daniel B; McKay Paul F; Schmitz Joern E; Santra Sampa; Subbramanian Ramu A; Kuroda Marcelo J; Lifton Michelle A; Gorgone Darci A; Wyatt Linda S; Moss Bernard; Huang Yue; Chakrabarti Bimal K; Xu Ling; Kong Wing-Pui; Yang Zhi-Yong; Mascola John R; Nabel Gary J; Carville Angela; Lackner Andrew A; Veazey Ronald S; Letvin Norman L
Elicitation of simian immunodeficiency virus-specific cytotoxic T lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination.
Journal of virology 2002;76(22):11484-90.
2002: Senkevich Tatiana G; White Christine L; Weisberg Andrea; Granek Joshua A; Wolffe Elizabeth J; Koonin Eugene V; Moss Bernard
Expression of the vaccinia virus A2.5L redox protein is required for virion morphogenesis.
Virology 2002;300(2):296-303.
2002: Domi Arban; Moss Bernard
Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(19):12415-20.
2002: Center Rob J; Leapman Richard D; Lebowitz Jacob; Arthur Larry O; Earl Patricia L; Moss Bernard
Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface.
Journal of virology 2002;76(15):7863-7.
2002: Husain Matloob; Moss Bernard
Similarities in the induction of post-Golgi vesicles by the vaccinia virus F13L protein and phospholipase D.
Journal of virology 2002;76(15):7777-89.
2002: Amara Rama Rao; Villinger Francois; Staprans Silvija I; Altman John D; Montefiori David C; Kozyr Natalia L; Xu Yan; Wyatt Linda S; Earl Patricia L; Herndon James G; McClure Harold M; Moss Bernard; Robinson Harriet L
Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines.
Journal of virology 2002;76(15):7625-31.
2002: Shchelkunov S N; Totmenin A V; Safronov P F; Mikheev M V; Gutorov V V; Ryazankina O I; Petrov N A; Babkin I V; Uvarova E A; Sandakhchiev L S; Sisler J R; Esposito J J; Damon I K; Jahrling P B; Moss B
Analysis of the monkeypox virus genome.
Virology 2002;297(2):172-94.
2002: Santra Sampa; Barouch Dan H; Kuroda Marcelo J; Schmitz Jörn E; Krivulka Georgia R; Beaudry Kristin; Lord Carol I; Lifton Michelle A; Wyatt Linda S; Moss Bernard; Hirsch Vanessa M; Letvin Norman L
Prior vaccination increases the epitopic breadth of the cytotoxic T-lymphocyte response that evolves in rhesus monkeys following a simian-human immunodeficiency virus infection.
Journal of virology 2002;76(12):6376-81.
2002: Amara Rama Rao; Smith James M; Staprans Silvija I; Montefiori David C; Villinger Francois; Altman John D; O'Neil Shawn P; Kozyr Natalia L; Xu Yan; Wyatt Linda S; Earl Patricia L; Herndon James G; McNicholl Janet M; McClure Harold M; Moss Bernard; Robinson Harriet L
Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine.
Journal of virology 2002;76(12):6138-46.
2002: Shchelkunov S N; Totmenin A V; Safronov P F; Gutorov V V; Ryazankina O I; Petrov N A; Babkin I V; Uvarova E A; Mikheev M V; Sisler J R; Esposito J J; Jahrling P B; Moss B; Sandakhchiev L S
Multiple genetic differences between the monkeypox and variola viruses.
Doklady. Biochemistry and biophysics 2002;384():143-7.
2002: Senkevich Tatiana G; White Christine L; Koonin Eugene V; Moss Bernard
Complete pathway for protein disulfide bond formation encoded by poxviruses.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(10):6667-72.
2002: Amara Rama Rao; Villinger Francois; Altman John D; Lydy Shari L; O'Neil Shawn P; Staprans Silvija I; Montefiori David C; Xu Yan; Herndon James G; Wyatt Linda S; Candido Maria Angelito; Kozyr Natalia L; Earl Patricia L; Smith James M; Ma Hak-Ling; Grimm Bennett D; Hulsey Michael L; McClure Harold M; McNicholl Janet M; Moss Bernard; Robinson Harriet L
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
Vaccine 2002;20(15):1949-55.
2002: Earl Patricia L; Wyatt Linda S; Montefiori David C; Bilska Miroslawa; Woodward Ruth; Markham Phillip D; Malley James D; Vogel Thorsten U; Allen Todd M; Watkins David I; Miller Nancy; Moss Bernard
Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model.
Virology 2002;294(2):270-81.
2002: White Christine L; Senkevich Tatiana G; Moss Bernard
Vaccinia virus G4L glutaredoxin is an essential intermediate of a cytoplasmic disulfide bond pathway required for virion assembly.
Journal of virology 2002;76(2):467-72.
2001: Center R J; Schuck P; Leapman R D; Arthur L O; Earl P L; Moss B; Lebowitz J
Oligomeric structure of virion-associated and soluble forms of the simian immunodeficiency virus envelope protein in the prefusion activated conformation.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(26):14877-82.
2001: McCart J A; Ward J M; Lee J; Hu Y; Alexander H R; Libutti S K; Moss B; Bartlett D L
Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.
Cancer research 2001;61(24):8751-7.
2001: Ward B M; Moss B
Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails.
Journal of virology 2001;75(23):11651-63.
2001: Shchelkunov S N; Totmenin A V; Babkin I V; Safronov P F; Ryazankina O I; Petrov N A; Gutorov V V; Uvarova E A; Mikheev M V; Sisler J R; Esposito J J; Jahrling P B; Moss B; Sandakhchiev L S
Human monkeypox and smallpox viruses: genomic comparison.
FEBS letters 2001;509(1):66-70.
2001: Moss B; Ward B M
High-speed mass transit for poxviruses on microtubules.
Nature cell biology 2001;3(11):E245-6.
2001: Szajner P; Weisberg A S; Moss B
Unique temperature-sensitive defect in vaccinia virus morphogenesis maps to a single nucleotide substitution in the A30L gene.
Journal of virology 2001;75(22):11222-6.
2001: Hu Y; Lee J; McCart J A; Xu H; Moss B; Alexander H R; Bartlett D L
Yaba-like disease virus: an alternative replicating poxvirus vector for cancer gene therapy.
Journal of virology 2001;75(21):10300-8.
2001: Xiang Y; Moss B
Correspondence of the functional epitopes of poxvirus and human interleukin-18-binding proteins.
Journal of virology 2001;75(20):9947-54.
2001: Husain M; Moss B
Vaccinia virus F13L protein with a conserved phospholipase catalytic motif induces colocalization of the B5R envelope glycoprotein in post-Golgi vesicles.
Journal of virology 2001;75(16):7528-42.
2001: Garcia A D; Moss B
Repression of vaccinia virus Holliday junction resolvase inhibits processing of viral DNA into unit-length genomes.
Journal of virology 2001;75(14):6460-71.
2001: Szajner P; Weisberg A S; Wolffe E J; Moss B
Vaccinia virus A30L protein is required for association of viral membranes with dense viroplasm to form immature virions.
Journal of virology 2001;75(13):5752-61.
2001: Stittelaar K J; Kuiken T; de Swart R L; van Amerongen G; Vos H W; Niesters H G; van Schalkwijk P; van der Kwast T; Wyatt L S; Moss B; Osterhaus A D
Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques.
Vaccine 2001;19(27):3700-9.
2001: Barouch D H; Santra S; Kuroda M J; Schmitz J E; Plishka R; Buckler-White A; Gaitan A E; Zin R; Nam J H; Wyatt L S; Lifton M A; Nickerson C E; Moss B; Montefiori D C; Hirsch V M; Letvin N L
Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination.
Journal of virology 2001;75(11):5151-8.
2001: Elroy-Stein O; Moss B
Gene expression using the vaccinia virus/ T7 RNA polymerase hybrid system.
Current protocols in protein science / editorial board, John E. Coligan ... [et al.] 2001;Chapter 5():Unit5.15.
2001: Earl P L; Moss B
Characterization of recombinant vaccinia viruses and their products.
Current protocols in protein science / editorial board, John E. Coligan ... [et al.] 2001;Chapter 5():Unit5.14.
2001: Earl P L; Moss B; Wyatt L S; Carroll M W
Generation of recombinant vaccinia viruses.
Current protocols in protein science / editorial board, John E. Coligan ... [et al.] 2001;Chapter 5():Unit5.13.
2001: Earl P L; Cooper N; Wyatt L S; Moss B; Carroll M W
Preparation of cell cultures and vaccinia virus stocks.
Current protocols in protein science / editorial board, John E. Coligan ... [et al.] 2001;Chapter 5():Unit5.12.
2001: Moss B; Earl P L
Overview of the vaccinia virus expression system.
Current protocols in protein science / editorial board, John E. Coligan ... [et al.] 2001;Chapter 5():Unit5.11.
2001: Elroy-Stein O; Moss B
Gene expression using the vaccinia virus/T7 RNA polymerase hybrid system.
Current protocols in molecular biology / edited by Frederick M. Ausubel ... [et al.] 2001;Chapter 16():Unit16.19.
2001: Earl P L; Moss B
Characterization of recombinant vaccinia viruses and their products.
Current protocols in molecular biology / edited by Frederick M. Ausubel ... [et al.] 2001;Chapter 16():Unit16.18.
2001: Earl P L; Moss B; Wyatt L S; Carroll M W
Generation of recombinant vaccinia viruses.
Current protocols in molecular biology / edited by Frederick M. Ausubel ... [et al.] 2001;Chapter 16():Unit16.17.
2001: Earl P L; Cooper N; Wyatt L S; Moss B; Carroll M W
Preparation of cell cultures and vaccinia virus stocks.
Current protocols in molecular biology / edited by Frederick M. Ausubel ... [et al.] 2001;Chapter 16():Unit16.16.
2001: Ward B M; Moss B
Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera.
Journal of virology 2001;75(10):4802-13.
2001: Kovacs G R; Vasilakis N; Moss B
Regulation of viral intermediate gene expression by the vaccinia virus B1 protein kinase.
Journal of virology 2001;75(9):4048-55.
2001: Xiang Y; Moss B
Determination of the functional epitopes of human interleukin-18-binding protein by site-directed mutagenesis.
The Journal of biological chemistry 2001;276(20):17380-6.
2001: Amara R R; Villinger F; Altman J D; Lydy S L; O'Neil S P; Staprans S I; Montefiori D C; Xu Y; Herndon J G; Wyatt L S; Candido M A; Kozyr N L; Earl P L; Smith J M; Ma H L; Grimm B D; Hulsey M L; Miller J; McClure H M; McNicholl J M; Moss B; Robinson H L
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
Science (New York, N.Y.) 2001;292(5514):69-74.
2001: Shisler J L; Moss B
Molluscum contagiosum virus inhibitors of apoptosis: The MC159 v-FLIP protein blocks Fas-induced activation of procaspases and degradation of the related MC160 protein.
Virology 2001;282(1):14-25.
2001: Barouch D H; Craiu A; Santra S; Egan M A; Schmitz J E; Kuroda M J; Fu T M; Nam J H; Wyatt L S; Lifton M A; Krivulka G R; Nickerson C E; Lord C I; Moss B; Lewis M G; Hirsch V M; Shiver J W; Letvin N L
Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys.
Journal of virology 2001;75(5):2462-7.
2001: Shisler J L; Moss B
Immunology 102 at poxvirus U: avoiding apoptosis.
Seminars in immunology 2001;13(1):67-72.
2001: Moss B; Shisler J L
Immunology 101 at poxvirus U: immune evasion genes.
Seminars in immunology 2001;13(1):59-66.
2001: Ishii K; Moss B
Role of vaccinia virus A20R protein in DNA replication: construction and characterization of temperature-sensitive mutants.
Journal of virology 2001;75(4):1656-63.
2001: Calderara S; Xiang Y; Moss B
Orthopoxvirus IL-18 binding proteins: affinities and antagonist activities.
Virology 2001;279(1):22-6.
2001: Earl P L; Sugiura W; Montefiori D C; Broder C C; Lee S A; Wild C; Lifson J; Moss B
Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140.
Journal of virology 2001;75(2):645-53.
2001: Wolffe E J; Weisberg A S; Moss B
The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein.
Journal of virology 2001;75(1):303-10.
2000: Senkevich T G; Weisberg A S; Moss B
Vaccinia virus E10R protein is associated with the membranes of intracellular mature virions and has a role in morphogenesis.
Virology 2000;278(1):244-52.
2000: Moss B; Shisler J L; Xiang Y; Senkevich T G
Immune-defense molecules of molluscum contagiosum virus, a human poxvirus.
Trends in microbiology 2000;8(10):473-7.
2000: Senkevich T G; White C L; Koonin E V; Moss B
A viral member of the ERV1/ALR protein family participates in a cytoplasmic pathway of disulfide bond formation.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(22):12068-73.
2000: Zhu Y d; Rota P; Wyatt L; Tamin A; Rozenblatt S; Lerche N; Moss B; Bellini W; McChesney M
Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody.
Virology 2000;276(1):202-13.
2000: Yeh W W; Moss B; Wolffe E J
The vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis.
Journal of virology 2000;74(20):9701-11.
2000: White C L; Weisberg A S; Moss B
A glutaredoxin, encoded by the G4L gene of vaccinia virus, is essential for virion morphogenesis.
Journal of virology 2000;74(19):9175-83.
2000: da Fonseca F G; Wolffe E J; Weisberg A; Moss B
Effects of deletion or stringent repression of the H3L envelope gene on vaccinia virus replication.
Journal of virology 2000;74(16):7518-28.
2000: da Fonseca F G; Wolffe E J; Weisberg A; Moss B
Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tail.
Journal of virology 2000;74(16):7508-17.
2000: Garcia A D; Aravind L; Koonin E V; Moss B
Bacterial-type DNA holliday junction resolvases in eukaryotic viruses.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(16):8926-31.
2000: Men R; Wyatt L; Tokimatsu I; Arakaki S; Shameem G; Elkins R; Chanock R; Moss B; Lai C J
Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge.
Vaccine 2000;18(27):3113-22.
2000: Allen T M; Vogel T U; Fuller D H; Mothé B R; Steffen S; Boyson J E; Shipley T; Fuller J; Hanke T; Sette A; Altman J D; Moss B; McMichael A J; Watkins D I
Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(9):4968-78.
2000: Center R J; Earl P L; Lebowitz J; Schuck P; Moss B
The human immunodeficiency virus type 1 gp120 V2 domain mediates gp41-independent intersubunit contacts.
Journal of virology 2000;74(10):4448-55.
2000: Stittelaar K J; Wyatt L S; de Swart R L; Vos H W; Groen J; van Amerongen G; van Binnendijk R S; Rozenblatt S; Moss B; Osterhaus A D
Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.
Journal of virology 2000;74(9):4236-43.
2000: Betakova T; Wolffe E J; Moss B
The vaccinia virus A14.5L gene encodes a hydrophobic 53-amino-acid virion membrane protein that enhances virulence in mice and is conserved among vertebrate poxviruses.
Journal of virology 2000;74(9):4085-92.
2000: McCraith S; Holtzman T; Moss B; Fields S
Genome-wide analysis of vaccinia virus protein-protein interactions.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(9):4879-84.
2000: Ward B M; Moss B
Golgi network targeting and plasma membrane internalization signals in vaccinia virus B5R envelope protein.
Journal of virology 2000;74(8):3771-80.
2000: Ourmanov I; Brown C R; Moss B; Carroll M; Wyatt L; Pletneva L; Goldstein S; Venzon D; Hirsch V M
Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.
Journal of virology 2000;74(6):2740-51.
2000: Seth A; Ourmanov I; Schmitz J E; Kuroda M J; Lifton M A; Nickerson C E; Wyatt L; Carroll M; Moss B; Venzon D; Letvin N L; Hirsch V M
Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge.
Journal of virology 2000;74(6):2502-9.
2000: Betakova T; Moss B
Disulfide bonds and membrane topology of the vaccinia virus A17L envelope protein.
Journal of virology 2000;74(5):2438-42.
1999: Crawford J M; Earl P L; Moss B; Reimann K A; Wyand M S; Manson K H; Bilska M; Zhou J T; Pauza C D; Parren P W; Burton D R; Sodroski J G; Letvin N L; Montefiori D C
Characterization of primary isolate-like variants of simian-human immunodeficiency virus.
Journal of virology 1999;73(12):10199-207.
1999: Wyatt L S; Whitehead S S; Venanzi K A; Murphy B R; Moss B
Priming and boosting immunity to respiratory syncytial virus by recombinant replication-defective vaccinia virus MVA.
Vaccine 1999;18(5-6):392-7.
1999: Shisler J L; Isaacs S N; Moss B
Vaccinia virus serpin-1 deletion mutant exhibits a host range defect characterized by low levels of intermediate and late mRNAs.
Virology 1999;262(2):298-311.
1999: Xiang Y; Moss B
IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(20):11537-42.
1999: Betakova T; Wolffe E J; Moss B
Membrane topology of the vaccinia virus A17L envelope protein.
Virology 1999;261(2):347-56.
1999: Katsafanas G C; Moss B
Histidine codons appended to the gene encoding the RPO22 subunit of vaccinia virus RNA polymerase facilitate the isolation and purification of functional enzyme and associated proteins from virus-infected cells.
Virology 1999;258(2):469-79.
1999: Durbin A P; Cho C J; Elkins W R; Wyatt L S; Moss B; Murphy B R
Comparison of the immunogenicity and efficacy of a replication-defective vaccinia virus expressing antigens of human parainfluenza virus type 3 (HPIV3) with those of a live attenuated HPIV3 vaccine candidate in rhesus monkeys passively immunized with PIV3 antibodies.
The Journal of infectious diseases 1999;179(6):1345-51.
1999: Xiang Y; Moss B
Identification of human and mouse homologs of the MC51L-53L-54L family of secreted glycoproteins encoded by the Molluscum contagiosum poxvirus.
Virology 1999;257(2):297-302.
1999: Betakova T; Wolffe E J; Moss B
Regulation of vaccinia virus morphogenesis: phosphorylation of the A14L and A17L membrane proteins and C-terminal truncation of the A17L protein are dependent on the F10L kinase.
Journal of virology 1999;73(5):3534-43.
1999: Belyakov I M; Moss B; Strober W; Berzofsky J A
Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(8):4512-7.
1999: Overwijk W W; Lee D S; Surman D R; Irvine K R; Touloukian C E; Chan C C; Carroll M W; Moss B; Rosenberg S A; Restifo N P
Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(6):2982-7.
1999: Sanz P; Moss B
Identification of a transcription factor, encoded by two vaccinia virus early genes, that regulates the intermediate stage of viral gene expression.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(6):2692-7.
1999: Sugiura W; Broder C C; Moss B; Earl P L
Characterization of conformation-dependent anti-gp120 murine monoclonal antibodies produced by immunization with monomeric and oligomeric human immunodeficiency virus type 1 envelope proteins.
Virology 1999;254(2):257-67.
1999: Roper R L; Moss B
Envelope formation is blocked by mutation of a sequence related to the HKD phospholipid metabolism motif in the vaccinia virus F13L protein.
Journal of virology 1999;73(2):1108-17.
1999: Nam J H; Wyatt L S; Chae S L; Cho H W; Park Y K; Moss B
Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes.
Vaccine 1999;17(3):261-8.
1999: Shors T; Keck J G; Moss B
Down regulation of gene expression by the vaccinia virus D10 protein.
Journal of virology 1999;73(1):791-6.
1998: Carroll M W; Overwijk W W; Surman D R; Tsung K; Moss B; Restifo N P
Construction and characterization of a triple-recombinant vaccinia virus encoding B7-1, interleukin 12, and a model tumor antigen.
Journal of the National Cancer Institute 1998;90(24):1881-7.
1998: Belyakov I M; Ahlers J D; Brandwein B Y; Earl P; Kelsall B L; Moss B; Strober W; Berzofsky J A
The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12.
The Journal of clinical investigation 1998;102(12):2072-81.
1998: Wyatt L S; Carroll M W; Czerny C P; Merchlinsky M; Sisler J R; Moss B
Marker rescue of the host range restriction defects of modified vaccinia virus Ankara.
Virology 1998;251(2):334-42.
1998: Senkevich T G; Moss B
Domain structure, intracellular trafficking, and beta2-microglobulin binding of a major histocompatibility complex class I homolog encoded by molluscum contagiosum virus.
Virology 1998;250(2):397-407.
1998: Belyakov I M; Wyatt L S; Ahlers J D; Earl P; Pendleton C D; Kelsall B L; Strober W; Moss B; Berzofsky J A
Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.
Journal of virology 1998;72(10):8264-72.
1998: Berger E A; Moss B; Pastan I
Reconsidering targeted toxins to eliminate HIV infection: you gotta have HAART.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(20):11511-3.
1998: Seth A; Ourmanov I; Kuroda M J; Schmitz J E; Carroll M W; Wyatt L S; Moss B; Forman M A; Hirsch V M; Letvin N L
Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(17):10112-6.
1998: Durbin A P; Wyatt L S; Siew J; Moss B; Murphy B R
The immunogenicity and efficacy of intranasally or parenterally administered replication-deficient vaccinia-parainfluenza virus type 3 recombinants in rhesus monkeys.
Vaccine 1998;16(13):1324-30.
1998: Sanz P; Moss B
A new vaccinia virus intermediate transcription factor.
Journal of virology 1998;72(8):6880-3.
1998: Overwijk W W; Tsung A; Irvine K R; Parkhurst M R; Goletz T J; Tsung K; Carroll M W; Liu C; Moss B; Rosenberg S A; Restifo N P
gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand.
The Journal of experimental medicine 1998;188(2):277-86.
1998: Cassetti M C; Merchlinsky M; Wolffe E J; Weisberg A S; Moss B
DNA packaging mutant: repression of the vaccinia virus A32 gene results in noninfectious, DNA-deficient, spherical, enveloped particles.
Journal of virology 1998;72(7):5769-80.
1998: Damon I; Murphy P M; Moss B
Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(11):6403-7.
1998: Roper R L; Wolffe E J; Weisberg A; Moss B
The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus.
Journal of virology 1998;72(5):4192-204.
1998: Wolffe E J; Weisberg A S; Moss B
Role for the vaccinia virus A36R outer envelope protein in the formation of virus-tipped actin-containing microvilli and cell-to-cell virus spread.
Virology 1998;244(1):20-6.
1998: Bugert J J; Lohmüller C; Damon I; Moss B; Darai G
Chemokine homolog of molluscum contagiosum virus: sequence conservation and expression.
Virology 1998;242(1):51-9.
1998: Ramsey-Ewing A; Moss B
Apoptosis induced by a postbinding step of vaccinia virus entry into Chinese hamster ovary cells.
Virology 1998;242(1):138-49.
1998: Belyakov I M; Derby M A; Ahlers J D; Kelsall B L; Earl P; Moss B; Strober W; Berzofsky J A
Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(4):1709-14.
1998: Hu X; Wolffe E J; Weisberg A S; Carroll L J; Moss B
Repression of the A8L gene, encoding the early transcription factor 82-kilodalton subunit, inhibits morphogenesis of vaccinia virions.
Journal of virology 1998;72(1):104-12.
1998: Shisler J L; Senkevich T G; Berry M J; Moss B
Ultraviolet-induced cell death blocked by a selenoprotein from a human dermatotropic poxvirus.
Science (New York, N.Y.) 1998;279(5347):102-5.
1997: Chakrabarti S; Sisler J R; Moss B
Compact, synthetic, vaccinia virus early/late promoter for protein expression.
BioTechniques 1997;23(6):1094-7.
1997: Carroll M W; Moss B
Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line.
Virology 1997;238(2):198-211.
1997: Katz E; Moss B
Immunogenicity of recombinant vaccinia viruses that display the HIV type 1 envelope glycoprotein on the surface of infectious virions.
AIDS research and human retroviruses 1997;13(17):1497-500.
1997: Carroll M W; Moss B
Poxviruses as expression vectors.
Current opinion in biotechnology 1997;8(5):573-7.
1997: Katsafanas G C; Grem J L; Blough H A; Moss B
Inhibition of vaccinia virus replication by N-(phosphonoacetyl)-L-aspartate: differential effects on viral gene expression result from a reduced pyrimidine nucleotide pool.
Virology 1997;236(1):177-87.
1997: Sung T C; Roper R L; Zhang Y; Rudge S A; Temel R; Hammond S M; Morris A J; Moss B; Engebrecht J; Frohman M A
Mutagenesis of phospholipase D defines a superfamily including a trans-Golgi viral protein required for poxvirus pathogenicity.
The EMBO journal 1997;16(15):4519-30.
1997: Yang S; Carroll M W; Torres-Duarte A P; Moss B; Davidson E A
Addition of the MSA1 signal and anchor sequences to the malaria merozoite surface antigen 1 C-terminal region enhances immunogenicity when expressed by recombinant vaccinia virus.
Vaccine 1997;15(12-13):1303-13.
1997: Senkevich T G; Koonin E V; Bugert J J; Darai G; Moss B
The genome of molluscum contagiosum virus: analysis and comparison with other poxviruses.
Virology 1997;233(1):19-42.
1997: Wolffe E J; Katz E; Weisberg A; Moss B
The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus.
Journal of virology 1997;71(5):3904-15.
1997: Bronte V; Carroll M W; Goletz T J; Wang M; Overwijk W W; Marincola F; Rosenberg S A; Moss B; Restifo N P
Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(7):3183-8.
1997: Katz E; Wolffe E J; Moss B
The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions.
Journal of virology 1997;71(4):3178-87.
1997: Earl P L; Broder C C; Doms R W; Moss B
Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein.
Journal of virology 1997;71(4):2674-84.
1997: Carroll M W; Overwijk W W; Chamberlain R S; Rosenberg S A; Moss B; Restifo N P
Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model.
Vaccine 1997;15(4):387-94.
1997: Bertin J; Armstrong R C; Ottilie S; Martin D A; Wang Y; Banks S; Wang G H; Senkevich T G; Alnemri E S; Moss B; Lenardo M J; Tomaselli K J; Cohen J I
Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(4):1172-6.
1996: Hu X; Carroll L J; Wolffe E J; Moss B
De novo synthesis of the early transcription factor 70-kilodalton subunit is required for morphogenesis of vaccinia virions.
Journal of virology 1996;70(11):7669-77.
1996: Wyatt L S; Shors S T; Murphy B R; Moss B
Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model.
Vaccine 1996;14(15):1451-8.
1996: Moss B
Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(21):11341-8.
1996: Kovacs G R; Moss B
The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression.
Journal of virology 1996;70(10):6796-802.
1996: Bender B S; Rowe C A; Taylor S F; Wyatt L S; Moss B; Small P A
Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza.
Journal of virology 1996;70(9):6418-24.
1996: Ramsey-Ewing A L; Moss B
Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene.
Virology 1996;222(1):75-86.
1996: Senkevich T G; Bugert J J; Sisler J R; Koonin E V; Darai G; Moss B
Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes.
Science (New York, N.Y.) 1996;273(5276):813-6.
1996: Cassetti M A; Moss B
Interaction of the 82-kDa subunit of the vaccinia virus early transcription factor heterodimer with the promoter core sequence directs downstream DNA binding of the 70-kDa subunit.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(15):7540-5.
1996: Passarelli A L; Kovacs G R; Moss B
Transcription of a vaccinia virus late promoter template: requirement for the product of the A2L intermediate-stage gene.
Journal of virology 1996;70(7):4444-50.
1996: Ramsey-Ewing A; Moss B
Recombinant protein synthesis in Chinese hamster ovary cells using a vaccinia virus/bacteriophage T7 hybrid expression system.
The Journal of biological chemistry 1996;271(28):16962-6.
1996: Chamberlain R S; Carroll M W; Bronte V; Hwu P; Warren S; Yang J C; Nishimura M; Moss B; Rosenberg S A; Restifo N P
Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines.
Cancer research 1996;56(12):2832-6.
1996: Roper R L; Payne L G; Moss B
Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene.
Journal of virology 1996;70(6):3753-62.
1996: Hirsch V M; Fuerst T R; Sutter G; Carroll M W; Yang L C; Goldstein S; Piatak M; Elkins W R; Alvord W G; Montefiori D C; Moss B; Lifson J D
Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.
Journal of virology 1996;70(6):3741-52.
1996: Otteken A; Earl P L; Moss B
Folding, assembly, and intracellular trafficking of the human immunodeficiency virus type 1 envelope glycoprotein analyzed with monoclonal antibodies recognizing maturational intermediates.
Journal of virology 1996;70(6):3407-15.
1996: Wolffe E J; Moore D M; Peters P J; Moss B
Vaccinia virus A17L open reading frame encodes an essential component of nascent viral membranes that is required to initiate morphogenesis.
Journal of virology 1996;70(5):2797-808.
1996: Rao J B; Chamberlain R S; Bronte V; Carroll M W; Irvine K R; Moss B; Rosenberg S A; Restifo N P
IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(9):3357-65.
1996: Weissenhorn W; Wharton S A; Calder L J; Earl P L; Moss B; Aliprandis E; Skehel J J; Wiley D C
The ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide.
The EMBO journal 1996;15(7):1507-14.
1996: Otteken A; Moss B
Calreticulin interacts with newly synthesized human immunodeficiency virus type 1 envelope glycoprotein, suggesting a chaperone function similar to that of calnexin.
The Journal of biological chemistry 1996;271(1):97-103.
1996: Gershon P; Moss B
Expression, purification, and characterization of vaccinia virus-encoded RNA and poly(A) polymerases.
Methods in enzymology 1996;275():208-27.
1996: Moss B; Carroll M W; Wyatt L S; Bennink J R; Hirsch V M; Goldstein S; Elkins W R; Fuerst T R; Lifson J D; Piatak M; Restifo N P; Overwijk W; Chamberlain R; Rosenberg S A; Sutter G
Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates.
Advances in experimental medicine and biology 1996;397():7-13.
1995: Rajagopal I; Ahn B Y; Moss B; Mathews C K
Roles of vaccinia virus ribonucleotide reductase and glutaredoxin in DNA precursor biosynthesis.
The Journal of biological chemistry 1995;270(46):27415-8.
1995: Carroll M W; Moss B
E. coli beta-glucuronidase (GUS) as a marker for recombinant vaccinia viruses.
BioTechniques 1995;19(3):352-4, 356.
1995: Wolffe E J; Vijaya S; Moss B
A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies.
Virology 1995;211(1):53-63.
1995: Ward G A; Stover C K; Moss B; Fuerst T R
Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(15):6773-7.
1995: Wyatt L S; Moss B; Rozenblatt S
Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells.
Virology 1995;210(1):202-5.
1995: Nussbaum O; Broder C C; Moss B; Stern L B; Rozenblatt S; Berger E A
Functional and structural interactions between measles virus hemagglutinin and CD46.
Journal of virology 1995;69(6):3341-9.
1995: Blasco R; Moss B
Selection of recombinant vaccinia viruses on the basis of plaque formation.
Gene 1995;158(2):157-62.
1995: Rehermann B; Fowler P; Sidney J; Person J; Redeker A; Brown M; Moss B; Sette A; Chisari F V
The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis.
The Journal of experimental medicine 1995;181(3):1047-58.
1995: Ramsey-Ewing A; Moss B
Restriction of vaccinia virus replication in CHO cells occurs at the stage of viral intermediate protein synthesis.
Virology 1995;206(2):984-93.
1995: Houghton M; Choo Q L; Kuo G; Weiner A; Chien D; Ralston R; Urdea M; Moss B; Purcell R; Cummins L
Prospects for prophylactic and therapeutic hepatitis C virus vaccines.
Princess Takamatsu symposia 1995;25():237-43.
1995: Sutter G; Moss B
Novel vaccinia vector derived from the host range restricted and highly attenuated MVA strain of vaccinia virus.
Developments in biological standardization 1995;84():195-200.
1994: Broder C C; Earl P L; Long D; Abedon S T; Moss B; Doms R W
Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(24):11699-703.
1994: Machesky L M; Cole N B; Moss B; Pollard T D
Vaccinia virus expresses a novel profilin with a higher affinity for polyphosphoinositides than actin.
Biochemistry 1994;33(35):10815-24.
1994: Baldick C J; Cassetti M C; Harris N; Moss B
Ordered assembly of a functional preinitiation transcription complex, containing vaccinia virus early transcription factor and RNA polymerase, on an immobilized template.
Journal of virology 1994;68(9):6052-6.
1994: Schnierle B S; Gershon P D; Moss B
Mutational analysis of a multifunctional protein, with mRNA 5' cap-specific (nucleoside-2'-O-)-methyltransferase and 3'-adenylyltransferase stimulatory activities, encoded by vaccinia virus.
The Journal of biological chemistry 1994;269(32):20700-6.
1994: Rimmelzwaan G F; Siebelink K H; Huisman R C; Moss B; Francis M J; Osterhaus A D
Removal of the cleavage site of recombinant feline immunodeficiency virus envelope protein facilitates incorporation of the surface glycoprotein in immune-stimulating complexes.
The Journal of general virology 1994;75 ( Pt 8)():2097-102.
1994: Sutter G; Wyatt L S; Foley P L; Bennink J R; Moss B
A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus.
Vaccine 1994;12(11):1032-40.
1994: Sutter G; Ramsey-Ewing A; Rosales R; Moss B
Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant.
Journal of virology 1994;68(7):4109-16.
1994: Rosales R; Harris N; Ahn B Y; Moss B
Purification and identification of a vaccinia virus-encoded intermediate stage promoter-specific transcription factor that has homology to eukaryotic transcription factor SII (TFIIS) and an additional role as a viral RNA polymerase subunit.
The Journal of biological chemistry 1994;269(19):14260-7.
1994: Kovacs G R; Rosales R; Keck J G; Moss B
Modification of the cascade model for regulation of vaccinia virus gene expression: purification of a prereplicative, late-stage-specific transcription factor.
Journal of virology 1994;68(5):3443-7.
1994: Earl P L; Broder C C; Long D; Lee S A; Peterson J; Chakrabarti S; Doms R W; Moss B
Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities.
Journal of virology 1994;68(5):3015-26.
1994: Rosales R; Sutter G; Moss B
A cellular factor is required for transcription of vaccinia viral intermediate-stage genes.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(9):3794-8.
1994: Ahn B Y; Gershon P D; Moss B
RNA polymerase-associated protein Rap94 confers promoter specificity for initiating transcription of vaccinia virus early stage genes.
The Journal of biological chemistry 1994;269(10):7552-7.
1994: Zhang Y; Ahn B Y; Moss B
Targeting of a multicomponent transcription apparatus into assembling vaccinia virus particles requires RAP94, an RNA polymerase-associated protein.
Journal of virology 1994;68(3):1360-70.
1994: Sodeik B; Griffiths G; Ericsson M; Moss B; Doms R W
Assembly of vaccinia virus: effects of rifampin on the intracellular distribution of viral protein p65.
Journal of virology 1994;68(2):1103-14.
1994: Moss B
Replicating and host-restricted non-replicating vaccinia virus vectors for vaccine development.
Developments in biological standardization 1994;82():55-63.
1993: Hügin A W; Flexner C; Moss B
Clearance of recombinant vaccinia virus expressing IL-2: role of local host immune responses.
Cellular immunology 1993;152(2):499-509.
1993: Gershon P D; Moss B
Uridylate-containing RNA sequences determine specificity for binding and polyadenylation by the catalytic subunit of vaccinia virus poly(A) polymerase.
The EMBO journal 1993;12(12):4705-14.
1993: Keck J G; Feigenbaum F; Moss B
Mutational analysis of a predicted zinc-binding motif in the 26-kilodalton protein encoded by the vaccinia virus A2L gene: correlation of zinc binding with late transcriptional transactivation activity.
Journal of virology 1993;67(10):5749-53.
1993: Keck J G; Kovacs G R; Moss B
Overexpression, purification, and late transcription factor activity of the 17-kilodalton protein encoded by the vaccinia virus A1L gene.
Journal of virology 1993;67(10):5740-8.
1993: Yuwen H; Cox J H; Yewdell J W; Bennink J R; Moss B
Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene.
Virology 1993;195(2):732-44.
1993: Wolffe E J; Isaacs S N; Moss B
Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination.
Journal of virology 1993;67(8):4732-41.
1993: Earl P L; Moss B
Mutational analysis of the assembly domain of the HIV-1 envelope glycoprotein.
AIDS research and human retroviruses 1993;9(7):589-94.
1993: Blasco R; Sisler J R; Moss B
Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene.
Journal of virology 1993;67(6):3319-25.
1993: Carroll K; Elroy-Stein O; Moss B; Jagus R
Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase.
The Journal of biological chemistry 1993;268(17):12837-42.
1993: Baldick C J; Moss B
Characterization and temporal regulation of mRNAs encoded by vaccinia virus intermediate-stage genes.
Journal of virology 1993;67(6):3515-27.
1993: Sodeik B; Doms R W; Ericsson M; Hiller G; Machamer C E; van 't Hof W; van Meer G; Moss B; Griffiths G
Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks.
The Journal of cell biology 1993;121(3):521-41.
1993: Harris N; Rosales R; Moss B
Transcription initiation factor activity of vaccinia virus capping enzyme is independent of mRNA guanylylation.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(7):2860-4.
1993: Karacostas V; Wolffe E J; Nagashima K; Gonda M A; Moss B
Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
Virology 1993;193(2):661-71.
1993: Moss B
Poxvirus vectors: cytoplasmic expression of transferred genes.
Current opinion in genetics & development 1993;3(1):86-90.
1993: Usdin T B; Brownstein M J; Moss B; Isaacs S N
SP6 RNA polymerase containing vaccinia virus for rapid expression of cloned genes in tissue culture.
BioTechniques 1993;14(2):222-4.
1993: Kennedy P E; Moss B; Berger E A
Primary HIV-1 isolates refractory to neutralization by soluble CD4 are potently inhibited by CD4-Pseudomonas exotoxin.
Virology 1993;192(1):375-9.
1993: Gershon P D; Moss B
Stimulation of poly(A) tail elongation by the VP39 subunit of the vaccinia virus-encoded poly(A) polymerase.
The Journal of biological chemistry 1993;268(3):2203-10.
1993: Ashorn P; Berger E A; Moss B
Vaccinia virus vectors for study of membrane fusion mediated by human immunodeficiency virus envelope glycoprotein and CD4.
Methods in enzymology 1993;221():12-8.
1992: Isaacs S N; Wolffe E J; Payne L G; Moss B
Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope.
Journal of virology 1992;66(12):7217-24.
1992: McKenzie R; Kotwal G J; Moss B; Hammer C H; Frank M M
Regulation of complement activity by vaccinia virus complement-control protein.
The Journal of infectious diseases 1992;166(6):1245-50.
1992: Sutter G; Moss B
Nonreplicating vaccinia vector efficiently expresses recombinant genes.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(22):10847-51.
1992: Zhang Y; Keck J G; Moss B
Transcription of viral late genes is dependent on expression of the viral intermediate gene G8R in cells infected with an inducible conditional-lethal mutant vaccinia virus.
Journal of virology 1992;66(11):6470-9.
1992: Moss B
Vaccinia and other poxvirus expression vectors.
Current opinion in biotechnology 1992;3(5):518-22.
1992: Merchlinsky M; Moss B
Introduction of foreign DNA into the vaccinia virus genome by in vitro ligation: recombination-independent selectable cloning vectors.
Virology 1992;190(1):522-6.
1992: Earl P L; Doms R W; Moss B
Multimeric CD4 binding exhibited by human and simian immunodeficiency virus envelope protein dimers.
Journal of virology 1992;66(9):5610-4.
1992: Baldick C J; Keck J G; Moss B
Mutational analysis of the core, spacer, and initiator regions of vaccinia virus intermediate-class promoters.
Journal of virology 1992;66(8):4710-9.
1992: Ahn B Y; Moss B
Glutaredoxin homolog encoded by vaccinia virus is a virion-associated enzyme with thioltransferase and dehydroascorbate reductase activities.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(15):7060-4.
1992: Gershon P D; Moss B
Transition from rapid processive to slow nonprocessive polyadenylation by vaccinia virus poly(A) polymerase catalytic subunit is regulated by the net length of the poly(A) tail.
Genes & development 1992;6(8):1575-86.
1992: Blasco R; Moss B
Role of cell-associated enveloped vaccinia virus in cell-to-cell spread.
Journal of virology 1992;66(7):4170-9.
1992: Schnierle B S; Moss B
Vaccinia virus-mediated inhibition of host protein synthesis involves neither degradation nor underphosphorylation of components of the cap-binding eukaryotic translation initiation factor complex eIF-4F.
Virology 1992;188(2):931-3.
1992: Amegadzie B Y; Ahn B Y; Moss B
Characterization of a 7-kilodalton subunit of vaccinia virus DNA-dependent RNA polymerase with structural similarities to the smallest subunit of eukaryotic RNA polymerase II.
Journal of virology 1992;66(5):3003-10.
1992: Alexander W A; Moss B; Fuerst T R
Regulated expression of foreign genes in vaccinia virus under the control of bacteriophage T7 RNA polymerase and the Escherichia coli lac repressor.
Journal of virology 1992;66(5):2934-42.
1992: Lieberman J; Fabry J A; Kuo M C; Earl P; Moss B; Skolnik P R
Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in Gp160 and reverse transcriptase.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(9):2738-47.
1992: Ahn B Y; Moss B
RNA polymerase-associated transcription specificity factor encoded by vaccinia virus.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(8):3536-40.
1992: Zhang Y; Moss B
Immature viral envelope formation is interrupted at the same stage by lac operator-mediated repression of the vaccinia virus D13L gene and by the drug rifampicin.
Virology 1992;187(2):643-53.
1992: Davies M V; Elroy-Stein O; Jagus R; Moss B; Kaufman R J
The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2.
Journal of virology 1992;66(4):1943-50.
1992: Schnierle B S; Gershon P D; Moss B
Cap-specific mRNA (nucleoside-O2'-)-methyltransferase and poly(A) polymerase stimulatory activities of vaccinia virus are mediated by a single protein.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(7):2897-901.
1992: Morgan R A; Couture L; Elroy-Stein O; Ragheb J; Moss B; Anderson W F
Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy.
Nucleic acids research 1992;20(6):1293-9.
1992: Amegadzie B Y; Sisler J R; Moss B
Frame-shift mutations within the vaccinia virus A-type inclusion protein gene.
Virology 1992;186(2):777-82.
1992: Ahn B Y; Rosel J; Cole N B; Moss B
Identification and expression of rpo19, a vaccinia virus gene encoding a 19-kilodalton DNA-dependent RNA polymerase subunit.
Journal of virology 1992;66(2):971-82.
1992: Penna A; Fowler P; Bertoletti A; Guilhot S; Moss B; Margolskee R F; Cavalli A; Valli A; Fiaccadori F; Chisari F V
Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTLs that recognize endogenously synthesized HBV envelope antigens.
Journal of virology 1992;66(2):1193-8.
1992: Isaacs S N; Kotwal G J; Moss B
Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(2):628-32.
1992: Yang X C; Labarca C; Nargeot J; Ho B Y; Elroy-Stein O; Moss B; Davidson N; Lester H A
Cell-specific posttranslational events affect functional expression at the plasma membrane but not tetrodotoxin sensitivity of the rat brain IIA sodium channel alpha-subunit expressed in mammalian cells.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1992;12(1):268-77.
1992: Ashorn P; Moss B; Berger E A
Activity of CD4-Pseudomonas exotoxin against cells expressing diverse forms of the HIV and SIV envelope glycoproteins.
Journal of acquired immune deficiency syndromes 1992;5(1):70-7.
1992: Moss B
Vaccinia virus vectors.
Biotechnology (Reading, Mass.) 1992;20():345-62.
1992: Moss B
Poxvirus expression vectors.
Current topics in microbiology and immunology 1992;158():25-38.
1992: Ashorn P; Moss B; Berger E A
Therapeutic strategies employing CD4, the HIV receptor.
Advances in experimental medicine and biology 1992;312():71-81.
1992: Mackett M; Smith G L; Moss B
Vaccinia virus: a selectable eukaryotic cloning and expression vector. 1982.
Biotechnology (Reading, Mass.) 1992;24():495-9.
1992: Kaslow D C; Bathurst I C; Isaacs S N; Keister D B; Moss B; Barr P J
Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant Pfs25.
Memórias do Instituto Oswaldo Cruz 1992;87 Suppl 3():175-7.
1991: Zhang Y F; Moss B
Vaccinia virus morphogenesis is interrupted when expression of the gene encoding an 11-kilodalton phosphorylated protein is prevented by the Escherichia coli lac repressor.
Journal of virology 1991;65(11):6101-10.
1991: Blasco R; Moss B
Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.
Journal of virology 1991;65(11):5910-20.
1991: Takahashi K; Dai L C; Fuerst T R; Biddison W E; Earl P L; Moss B; Ennis F A
Specific lysis of human immunodeficiency virus type 1-infected cells by a HLA-A3.1-restricted CD8+ cytotoxic T-lymphocyte clone that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(22):10277-81.
1991: Rooney J F; Wohlenberg C R; Moss B; Notkins A L
Live vaccinia virus recombinants expressing herpes simplex virus genes.
Reviews of infectious diseases 1991;13 Suppl 11():S898-903.
1991: Blasco R; Cole N B; Moss B
Sequence analysis, expression, and deletion of a vaccinia virus gene encoding a homolog of profilin, a eukaryotic actin-binding protein.
Journal of virology 1991;65(9):4598-608.
1991: Satchidanandam V; Zavala F; Moss B
Studies using a recombinant vaccinia virus expressing the circumsporozoite protein of Plasmodium berghei.
Molecular and biochemical parasitology 1991;48(1):89-99.
1991: Gershon P D; Ahn B Y; Garfield M; Moss B
Poly(A) polymerase and a dissociable polyadenylation stimulatory factor encoded by vaccinia virus.
Cell 1991;66(6):1269-78.
1991: Broyles S S; Li J; Moss B
Promoter DNA contacts made by the vaccinia virus early transcription factor.
The Journal of biological chemistry 1991;266(23):15539-44.
1991: Littaua R A; Oldstone M B; Takeda A; Debouck C; Wong J T; Tuazon C U; Moss B; Kievits F; Ennis F A
An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag.
Journal of virology 1991;65(8):4051-6.
1991: Wright C F; Keck J G; Tsai M M; Moss B
A transcription factor for expression of vaccinia virus late genes is encoded by an intermediate gene.
Journal of virology 1991;65(7):3715-20.
1991: Karschin A; Ho B Y; Labarca C; Elroy-Stein O; Moss B; Davidson N; Lester H A
Heterologously expressed serotonin 1A receptors couple to muscarinic K+ channels in heart.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(13):5694-8.
1991: Amegadzie B Y; Ahn B Y; Moss B
Identification, sequence, and expression of the gene encoding a Mr 35,000 subunit of the vaccinia virus DNA-dependent RNA polymerase.
The Journal of biological chemistry 1991;266(21):13712-8.
1991: Moss B
Vaccinia virus: a tool for research and vaccine development.
Science (New York, N.Y.) 1991;252(5013):1662-7.
1991: Kaslow D C; Isaacs S N; Quakyi I A; Gwadz R W; Moss B; Keister D B
Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus.
Science (New York, N.Y.) 1991;252(5010):1310-3.
1991: Zibert A; Selinka H C; Elroy-Stein O; Moss B; Wimmer E
Vaccinia virus-mediated expression and identification of the human poliovirus receptor.
Virology 1991;182(1):250-9.
1991: Yang X C; Karschin A; Labarca C; Elroy-Stein O; Moss B; Davidson N; Lester H A
Expression of ion channels and receptors in Xenopus oocytes using vaccinia virus.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1991;5(8):2209-16.
1991: Ashorn P; Englund G; Martin M A; Moss B; Berger E A
Anti-HIV activity of CD4-Pseudomonas exotoxin on infected primary human lymphocytes and monocyte/macrophages.
The Journal of infectious diseases 1991;163(4):703-9.
1991: Earl P L; Moss B; Doms R W
Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein.
Journal of virology 1991;65(4):2047-55.
1991: Zhang Y F; Moss B
Inducer-dependent conditional-lethal mutant animal viruses.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(4):1511-5.
1991: Moss B; Ahn B Y; Amegadzie B; Gershon P D; Keck J G
Cytoplasmic transcription system encoded by vaccinia virus.
The Journal of biological chemistry 1991;266(3):1355-8.
1991: Earl P L; Koenig S; Moss B
Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses.
Journal of virology 1991;65(1):31-41.
1991: Amegadzie B Y; Holmes M H; Cole N B; Jones E V; Earl P L; Moss B
Identification, sequence, and expression of the gene encoding the second-largest subunit of the vaccinia virus DNA-dependent RNA polymerase.
Virology 1991;180(1):88-98.
1991: Doms R W; Earl P L; Moss B
The assembly of the HIV-1 env glycoprotein into dimers and tetramers.
Advances in experimental medicine and biology 1991;300():203-19; discussion 220-1.
1990: Kotwal G J; Isaacs S N; McKenzie R; Frank M M; Moss B
Inhibition of the complement cascade by the major secretory protein of vaccinia virus.
Science (New York, N.Y.) 1990;250(4982):827-30.
1990: Moss B; Elroy-Stein O; Mizukami T; Alexander W A; Fuerst T R
Product review. New mammalian expression vectors.
Nature 1990;348(6296):91-2.
1990: Ashorn P; Moss B; Weinstein J N; Chaudhary V K; FitzGerald D J; Pastan I; Berger E A
Elimination of infectious human immunodeficiency virus from human T-cell cultures by synergistic action of CD4-Pseudomonas exotoxin and reverse transcriptase inhibitors.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(22):8889-93.
1990: Ahn B Y; Gershon P D; Jones E V; Moss B
Identification of rpo30, a vaccinia virus RNA polymerase gene with structural similarity to a eucaryotic transcription elongation factor.
Molecular and cellular biology 1990;10(10):5433-41.
1990: Doms R W; Blumenthal R; Moss B
Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane.
Journal of virology 1990;64(10):4884-92.
1990: Isaacs S N; Kotwal G J; Moss B
Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses.
Virology 1990;178(2):626-30.
1990: Ashorn P; McQuade T J; Thaisrivongs S; Tomasselli A G; Tarpley W G; Moss B
An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(19):7472-6.
1990: Elroy-Stein O; Moss B
Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(17):6743-7.
1990: Kinchington P R; Ling P; Pensiero M; Moss B; Ruyechan W T; Hay J
The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka).
Journal of virology 1990;64(9):4540-8.
1990: Moss B
Recombinant DNA virus vectors for vaccination.
Seminars in immunology 1990;2(5):317-27.
1990: Chakrabarti S; Mizukami T; Franchini G; Moss B
Synthesis, oligomerization, and biological activity of the human immunodeficiency virus type 2 envelope glycoprotein expressed by a recombinant vaccinia virus.
Virology 1990;178(1):134-42.
1990: Davison A J; Moss B
New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins.
Nucleic acids research 1990;18(14):4285-6.
1990: Doms R W; Earl P L; Chakrabarti S; Moss B
Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus env proteins possess a functionally conserved assembly domain.
Journal of virology 1990;64(7):3537-40.
1990: Koenig S; Fuerst T R; Wood L V; Woods R M; Suzich J A; Jones G M; de la Cruz V F; Davey R T; Venkatesan S; Moss B
Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(1):127-35.
1990: Keck J G; Baldick C J; Moss B
Role of DNA replication in vaccinia virus gene expression: a naked template is required for transcription of three late trans-activator genes.
Cell 1990;61(5):801-9.
1990: Ahn B Y; Jones E V; Moss B
Identification of the vaccinia virus gene encoding an 18-kilodalton subunit of RNA polymerase and demonstration of a 5' poly(A) leader on its early transcript.
Journal of virology 1990;64(6):3019-24.
1990: Gershon P D; Moss B
Early transcription factor subunits are encoded by vaccinia virus late genes.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(11):4401-5.
1990: Guo P X; Moss B
Interaction and mutual stabilization of the two subunits of vaccinia virus mRNA capping enzyme coexpressed in Escherichia coli.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(11):4023-7.
1990: Falkner F G; Moss B
Transient dominant selection of recombinant vaccinia viruses.
Journal of virology 1990;64(6):3108-11.
1990: Berger E A; Chaudhary V K; Clouse K A; Jaraquemada D; Nicholas J A; Rubino K L; Fitzgerald D J; Pastan I; Moss B
Recombinant CD4-Pseudomonas exotoxin hybrid protein displays HIV-specific cytotoxicity without affecting MHC class II-dependent functions.
AIDS research and human retroviruses 1990;6(6):795-804.
1990: Pantaleo G; De Maria A; Koenig S; Butini L; Moss B; Baseler M; Lane H C; Fauci A S
CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(12):4818-22.
1990: Mondelli M; Baldick J; McLachlan A; Chisari F V; Moss B
Expression of HBV envelope and nucleocapsid proteins in human cells using vaccinia virus vectors.
The Italian journal of gastroenterology 1990;22(3):115-7.
1990: Earl P L; Hügin A W; Moss B
Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus.
Journal of virology 1990;64(5):2448-51.
1990: Ashorn P A; Berger E A; Moss B
Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells.
Journal of virology 1990;64(5):2149-56.
1990: Moriyama T; Guilhot S; Klopchin K; Moss B; Pinkert C A; Palmiter R D; Brinster R L; Kanagawa O; Chisari F V
Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice.
Science (New York, N.Y.) 1990;248(4953):361-4.
1990: Polydefkis M; Koenig S; Flexner C; Obah E; Gebo K; Chakrabarti S; Earl P L; Moss B; Siliciano R F
Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition.
The Journal of experimental medicine 1990;171(3):875-87.
1990: Hosmalin A; Clerici M; Houghten R; Pendleton C D; Flexner C; Lucey D R; Moss B; Germain R N; Shearer G M; Berzofsky J A
An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(6):2344-8.
1990: Flexner C; Moss B; London W T; Murphy B R
Attenuation and immunogenicity in primates of vaccinia virus recombinants expressing human interleukin-2.
Vaccine 1990;8(1):17-21.
1990: Takahashi H; Germain R N; Moss B; Berzofsky J A
An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself.
The Journal of experimental medicine 1990;171(2):571-6.
1990: McQuade T J; Tomasselli A G; Liu L; Karacostas V; Moss B; Sawyer T K; Heinrikson R L; Tarpley W G
A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
Science (New York, N.Y.) 1990;247(4941):454-6.
1990: Earl P L; Doms R W; Moss B
Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(2):648-52.
1990: Moss B
Regulation of orthopoxvirus gene expression.
Current topics in microbiology and immunology 1990;163():41-70.
1990: Moss B
Regulation of vaccinia virus transcription.
Annual review of biochemistry 1990;59():661-88.
1990: Shuman S; Moss B
Purification and use of vaccinia virus messenger RNA capping enzyme.
Methods in enzymology 1990;181():170-80.
1990: Ashorn P; Moss B; Berger E A
Anti-HIV effects of CD4-Pseudomonas exotoxin on human lymphocyte and monocyte/macrophage cell lines.
Annals of the New York Academy of Sciences 1990;616():149-54.
1989: Shuman S; Moss B
Bromouridine triphosphate inhibits transcription termination and mRNA release by vaccinia virions.
The Journal of biological chemistry 1989;264(35):21356-60.
1989: Davison A J; Moss B
Structure of vaccinia virus late promoters.
Journal of molecular biology 1989;210(4):771-84.
1989: Davison A J; Moss B
Structure of vaccinia virus early promoters.
Journal of molecular biology 1989;210(4):749-69.
1989: Berger E A; Clouse K A; Chaudhary V K; Chakrabarti S; FitzGerald D J; Pastan I; Moss B
CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(23):9539-43.
1989: Walker B D; Flexner C; Birch-Limberger K; Fisher L; Paradis T J; Aldovini A; Young R; Moss B; Schooley R T
Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(23):9514-8.
1989: Takahashi H; Houghten R; Putney S D; Margulies D H; Moss B; Germain R N; Berzofsky J A
Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein.
The Journal of experimental medicine 1989;170(6):2023-35.
1989: Karacostas V; Nagashima K; Gonda M A; Moss B
Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(22):8964-7.
1989: Takahashi H; Merli S; Putney S D; Houghten R; Moss B; Germain R N; Berzofsky J A
A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160.
Science (New York, N.Y.) 1989;246(4926):118-21.
1989: Merchlinsky M; Moss B
Nucleotide sequence required for resolution of the concatemer junction of vaccinia virus DNA.
Journal of virology 1989;63(10):4354-61.
1989: Niles E G; Lee-Chen G J; Shuman S; Moss B; Broyles S S
Vaccinia virus gene D12L encodes the small subunit of the viral mRNA capping enzyme.
Virology 1989;172(2):513-22.
1989: Wright C F; Moss B
Identification of factors specific for transcription of the late class of vaccinia virus genes.
Journal of virology 1989;63(10):4224-33.
1989: Kotwal G J; Hügin A W; Moss B
Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da secreted protein.
Virology 1989;171(2):579-87.
1989: Elroy-Stein O; Fuerst T R; Moss B
Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(16):6126-30.
1989: Andreasson K I; Tam W W; Feurst T O; Moss B; Loh Y P
Production of pro-opiomelanocortin (POMC) by a vaccinia virus transient expression system and in vitro processing of the expressed prohormone by POMC-converting enzyme.
FEBS letters 1989;248(1-2):43-7.
1989: Shuman S; Golder M; Moss B
Insertional mutagenesis of the vaccinia virus gene encoding a type I DNA topoisomerase: evidence that the gene is essential for virus growth.
Virology 1989;170(1):302-6.
1989: Merchlinsky M; Moss B
Resolution of vaccinia virus DNA concatemer junctions requires late-gene expression.
Journal of virology 1989;63(4):1595-603.
1989: Barrett N; Mitterer A; Mundt W; Eibl J; Eibl M; Gallo R C; Moss B; Dorner F
Large-scale production and purification of a vaccinia recombinant-derived HIV-1 gp160 and analysis of its immunogenicity.
AIDS research and human retroviruses 1989;5(2):159-71.
1989: Fuerst T R; Fernandez M P; Moss B
Transfer of the inducible lac repressor/operator system from Escherichia coli to a vaccinia virus expression vector.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(8):2549-53.
1989: Fuerst T R; Moss B
Structure and stability of mRNA synthesized by vaccinia virus-encoded bacteriophage T7 RNA polymerase in mammalian cells. Importance of the 5' untranslated leader.
Journal of molecular biology 1989;206(2):333-48.
1989: Kotwal G J; Moss B
Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily.
Journal of virology 1989;63(2):600-6.
1989: Earl P L; Robert-Guroff M; Matthews T J; Krohn K; London W T; Moss B
Isolate- and group-specific immune responses to the envelope protein of human immunodeficiency virus induced by a live recombinant vaccinia virus in macaques.
AIDS research and human retroviruses 1989;5(1):23-32.
1989: Olmsted R A; Murphy B R; Lawrence L A; Elango N; Moss B; Collins P L
Processing, surface expression, and immunogenicity of carboxy-terminally truncated mutants of G protein of human respiratory syncytial virus.
Journal of virology 1989;63(1):411-20.
1989: Ahn B Y; Moss B
Capped poly(A) leaders of variable lengths at the 5' ends of vaccinia virus late mRNAs.
Journal of virology 1989;63(1):226-32.
1989: Moss B; Flexner C
Vaccinia virus expression vectors.
Annals of the New York Academy of Sciences 1989;569():86-103.
1989: Krohn K; Ranki A; Lusso P; Moss B; Ashorn P; Arthur L O; Putney S D; Gallo R C
Proliferative T-cell response to HIV envelope glycoprotein in immunized and infected primates and human beings.
Journal of medical primatology 1989;18(3-4):363-9.
1988: Kotwal G J; Moss B
Analysis of a large cluster of nonessential genes deleted from a vaccinia virus terminal transposition mutant.
Virology 1988;167(2):524-37.
1988: Willey D E; Cantin E M; Hill L R; Moss B; Notkins A L; Openshaw H
Herpes simplex virus type 1-vaccinia virus recombinant expressing glycoprotein B: protection from acute and latent infection.
The Journal of infectious diseases 1988;158(6):1382-6.
1988: Mizukami T; Fuerst T R; Berger E A; Moss B
Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(23):9273-7.
1988: Shuman S; Golder M; Moss B
Characterization of vaccinia virus DNA topoisomerase I expressed in Escherichia coli.
The Journal of biological chemistry 1988;263(31):16401-7.
1988: Koenig S; Earl P; Powell D; Pantaleo G; Merli S; Moss B; Fauci A S
Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(22):8638-42.
1988: Lusso P; Markham P D; Ranki A; Earl P; Moss B; Dorner F; Gallo R C; Krohn K J
Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(7):2467-73.
1988: Good M F; Miller L H; Kumar S; Quakyi I A; Keister D; Adams J H; Moss B; Berzofsky J A; Carter R
Limited immunological recognition of critical malaria vaccine candidate antigens.
Science (New York, N.Y.) 1988;242(4878):574-7.
1988: Flexner C; Broyles S S; Earl P; Chakrabarti S; Moss B
Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses.
Virology 1988;166(2):339-49.
1988: Kotwal G J; Moss B
Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins.
Nature 1988;335(6186):176-8.
1988: Chaudhary V K; Mizukami T; Fuerst T R; FitzGerald D J; Moss B; Pastan I; Berger E A
Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein.
Nature 1988;335(6188):369-72.
1988: Flexner C; Murphy B R; Rooney J F; Wohlenberg C; Yuferov V; Notkins A L; Moss B
Successful vaccination with a polyvalent live vector despite existing immunity to an expressed antigen.
Nature 1988;335(6187):259-62.
1988: Broyles S S; Yuen L; Shuman S; Moss B
Purification of a factor required for transcription of vaccinia virus early genes.
The Journal of biological chemistry 1988;263(22):10754-60.
1988: Broyles S S; Moss B
DNA-dependent ATPase activity associated with vaccinia virus early transcription factor.
The Journal of biological chemistry 1988;263(22):10761-5.
1988: McLaughlin-Taylor E; Willey D E; Cantin E M; Eberle R; Moss B; Openshaw H
A recombinant vaccinia virus expressing herpes simplex virus type 1 glycoprotein B induces cytotoxic T lymphocytes in mice.
The Journal of general virology 1988;69 ( Pt 7)():1731-4.
1988: Kumar S; Miller L H; Quakyi I A; Keister D B; Houghten R A; Maloy W L; Moss B; Berzofsky J A; Good M F
Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum.
Nature 1988;334(6179):258-60.
1988: Shepp D H; Chakrabarti S; Moss B; Quinnan G V
Antibody-dependent cellular cytotoxicity specific for the envelope antigens of human immunodeficiency virus.
The Journal of infectious diseases 1988;157(6):1260-4.
1988: Falkner F G; Moss B
Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors.
Journal of virology 1988;62(6):1849-54.
1988: Shuman S; Moss B
Vaccinia virus poly(A) polymerase. Specificity for nucleotides and nucleotide analogs.
The Journal of biological chemistry 1988;263(17):8405-12.
1988: Falkner F G; Fuerst T R; Moss B
Use of vaccinia virus vectors to study the synthesis, intracellular localization, and action of the human immunodeficiency virus trans-activator protein.
Virology 1988;164(2):450-7.
1988: Buller R M; Chakrabarti S; Moss B; Fredrickson T
Cell proliferative response to vaccinia virus is mediated by VGF.
Virology 1988;164(1):182-92.
1988: Shuman S; Moss B
Factor-dependent transcription termination by vaccinia virus RNA polymerase. Evidence that the cis-acting termination signal is in nascent RNA.
The Journal of biological chemistry 1988;263(13):6220-5.
1988: Rooney J F; Wohlenberg C; Cremer K J; Moss B; Notkins A L
Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination.
Journal of virology 1988;62(5):1530-4.
1988: Takahashi H; Cohen J; Hosmalin A; Cease K B; Houghten R; Cornette J L; DeLisi C; Moss B; Germain R N; Berzofsky J A
An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(9):3105-9.
1988: Vijaya S; Elango N; Zavala F; Moss B
Transport to the cell surface of a peptide sequence attached to the truncated C terminus of an N-terminally anchored integral membrane protein.
Molecular and cellular biology 1988;8(4):1709-14.
1988: Moss B; Fuerst T R; Flexner C; Hugin A
Roles of vaccinia virus in the development of new vaccines.
Vaccine 1988;6(2):161-3.
1988: Chanock R M; Murphy B R; Collins P L; Coelingh K V; Olmsted R A; Snyder M H; Spriggs M K; Prince G A; Moss B; Flores J
Live viral vaccines for respiratory and enteric tract diseases.
Vaccine 1988;6(2):129-33.
1988: Walker B D; Flexner C; Paradis T J; Fuller T C; Hirsch M S; Schooley R T; Moss B
HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals.
Science (New York, N.Y.) 1988;240(4848):64-6.
1988: Berger E A; Fuerst T R; Moss B
A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(7):2357-61.
1988: Buller R M; Chakrabarti S; Cooper J A; Twardzik D R; Moss B
Deletion of the vaccinia virus growth factor gene reduces virus virulence.
Journal of virology 1988;62(3):866-74.
1988: Merchlinsky M; Garon C F; Moss B
Molecular cloning and sequence of the concatemer junction from vaccinia virus replicative DNA. Viral nuclease cleavage sites in cruciform structures.
Journal of molecular biology 1988;199(3):399-413.
1988: Willey R L; Smith D H; Lasky L A; Theodore T S; Earl P L; Moss B; Capon D J; Martin M A
In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.
Journal of virology 1988;62(1):139-47.
1988: Moss B
Use of vaccinia virus vectors for development of AIDS vaccines.
AIDS (London, England) 1988;2 Suppl 1():S103-5.
1988: Yewdell J; Bennink J; Smith G; Moss B
Use of recombinant vaccinia viruses to examine cytotoxic T lymphocyte recognition of individual viral proteins.
Advances in experimental medicine and biology 1988;239():151-61.
1987: Wright C F; Moss B
In vitro synthesis of vaccinia virus late mRNA containing a 5' poly(A) leader sequence.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(24):8883-7.
1987: Esposito J; Brechling K; Baer G; Moss B
Vaccinia virus recombinants expressing rabiesvirus glycoprotein protect against rabies.
Virus genes 1987;1(1):7-21.
1987: Flexner C; Hügin A; Moss B
Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression.
Nature 1987;330(6145):259-62.
1987: Shuman S; Moss B
Identification of a vaccinia virus gene encoding a type I DNA topoisomerase.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(21):7478-82.
1987: Smith G L; Levin J Z; Palese P; Moss B
Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses.
Virology 1987;160(2):336-45.
1987: Morrison R P; Earl P L; Nishio J; Lodmell D L; Moss B; Chesebro B
Different H-2 subregions influence immunization against retrovirus and immunosuppression.
Nature 1987;329(6141):729-32.
1987: Shuman S; Broyles S S; Moss B
Purification and characterization of a transcription termination factor from vaccinia virions.
The Journal of biological chemistry 1987;262(25):12372-80.
1987: Yuen L; Moss B
Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genes.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(18):6417-21.
1987: Yuen L; Davison A J; Moss B
Early promoter-binding factor from vaccinia virions.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(17):6069-73.
1987: Falkner F G; Chakrabarti S; Moss B
pUV I: a new vaccinia virus insertion and expression vector.
Nucleic acids research 1987;15(17):7192.
1987: Cantin E M; Eberle R; Baldick J L; Moss B; Willey D E; Notkins A L; Openshaw H
Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(16):5908-12.
1987: Yilma T; Ristow S S; Moss B; Jones L
A novel approach for the production of monoclonal antibodies using infectious vaccinia virus recombinants.
Hybridoma 1987;6(4):329-35.
1987: Walker B D; Chakrabarti S; Moss B; Paradis T J; Flynn T; Durno A G; Blumberg R S; Kaplan J C; Hirsch M S; Schooley R T
HIV-specific cytotoxic T lymphocytes in seropositive individuals.
Nature 1987;328(6128):345-8.
1987: Fuerst T R; Earl P L; Moss B
Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes.
Molecular and cellular biology 1987;7(7):2538-44.
1987: Paterson R G; Lamb R A; Moss B; Murphy B R
Comparison of the relative roles of the F and HN surface glycoproteins of the paramyxovirus simian virus 5 in inducing protective immunity.
Journal of virology 1987;61(6):1972-7.
1987: Jones E V; Puckett C; Moss B
DNA-dependent RNA polymerase subunits encoded within the vaccinia virus genome.
Journal of virology 1987;61(6):1765-71.
1987: Weir J P; Moss B
Determination of the promoter region of an early vaccinia virus gene encoding thymidine kinase.
Virology 1987;158(1):206-10.
1987: Broyles S S; Moss B
Identification of the vaccinia virus gene encoding nucleoside triphosphate phosphohydrolase I, a DNA-dependent ATPase.
Journal of virology 1987;61(5):1738-42.
1987: Bennink J R; Yewdell J W; Smith G L; Moss B
Anti-influenza virus cytotoxic T lymphocytes recognize the three viral polymerases and a nonstructural protein: responsiveness to individual viral antigens is major histocompatibility complex controlled.
Journal of virology 1987;61(4):1098-102.
1987: Cheng K C; Moss B
Selective synthesis and secretion of particles composed of the hepatitis B virus middle surface protein directed by a recombinant vaccinia virus: induction of antibodies to pre-S and S epitopes.
Journal of virology 1987;61(4):1286-90.
1987: Martin S; Moss B; Berman P W; Laskey L A; Rouse B T
Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells.
Journal of virology 1987;61(3):726-34.
1987: Gotch F; McMichael A; Smith G; Moss B
Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes.
The Journal of experimental medicine 1987;165(2):408-16.
1987: Stamatos N M; Chakrabarti S; Moss B; Hare J D
Expression of polyomavirus virion proteins by a vaccinia virus vector: association of VP1 and VP2 with the nuclear framework.
Journal of virology 1987;61(2):516-25.
1987: Baldick C J; Moss B
Resistance of vaccinia virus to rifampicin conferred by a single nucleotide substitution near the predicted NH2 terminus of a gene encoding an Mr 62,000 polypeptide.
Virology 1987;156(1):138-45.
1987: Weir J P; Moss B
Determination of the transcriptional regulatory region of a vaccinia virus late gene.
Journal of virology 1987;61(1):75-80.
1987: Broyles S S; Moss B
Sedimentation of an RNA polymerase complex from vaccinia virus that specifically initiates and terminates transcription.
Molecular and cellular biology 1987;7(1):7-14.
1987: Moss B; Flexner C
Vaccinia virus expression vectors.
Annual review of immunology 1987;5():305-24.
1986: Earl P L; Moss B; Morrison R P; Wehrly K; Nishio J; Chesebro B
T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant.
Science (New York, N.Y.) 1986;234(4777):728-31.
1986: Fuerst T R; Niles E G; Studier F W; Moss B
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(21):8122-6.
1986: Rosel J L; Earl P L; Weir J P; Moss B
Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment.
Journal of virology 1986;60(2):436-49.
1986: Cheng K C; Smith G L; Moss B
Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus.
Journal of virology 1986;60(2):337-44.
1986: Yuen L; Moss B
Multiple 3' ends of mRNA encoding vaccinia virus growth factor occur within a series of repeated sequences downstream of T clusters.
Journal of virology 1986;60(1):320-3.
1986: Olmsted R A; Elango N; Prince G A; Murphy B R; Johnson P R; Moss B; Chanock R M; Collins P L
Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(19):7462-6.
1986: Lifson J D; Feinberg M B; Reyes G R; Rabin L; Banapour B; Chakrabarti S; Moss B; Wong-Staal F; Steimer K S; Engleman E G
Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.
Nature 1986;323(6090):725-8.
1986: Rohrmann G; Yuen L; Moss B
Transcription of vaccinia virus early genes by enzymes isolated from vaccinia virions terminates downstream of a regulatory sequence.
Cell 1986;46(7):1029-35.
1986: Langford C J; Edwards S J; Smith G L; Mitchell G F; Moss B; Kemp D J; Anders R F
Anchoring a secreted plasmodium antigen on the surface of recombinant vaccinia virus-infected cells increases its immunogenicity.
Molecular and cellular biology 1986;6(9):3191-9.
1986: Zarling J M; Moran P A; Lasky L A; Moss B
Herpes simplex virus (HSV)-specific human T-cell clones recognize HSV glycoprotein D expressed by a recombinant vaccinia virus.
Journal of virology 1986;59(2):506-9.
1986: Merchlinsky M; Moss B
Resolution of linear minichromosomes with hairpin ends from circular plasmids containing vaccinia virus concatemer junctions.
Cell 1986;45(6):879-84.
1986: Earl P L; Jones E V; Moss B
Homology between DNA polymerases of poxviruses, herpesviruses, and adenoviruses: nucleotide sequence of the vaccinia virus DNA polymerase gene.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(11):3659-63.
1986: Yewdell J W; Bennink J R; Mackett M; Lefrancois L; Lyles D S; Moss B
Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes.
The Journal of experimental medicine 1986;163(6):1529-38.
1986: Broyles S S; Moss B
Homology between RNA polymerases of poxviruses, prokaryotes, and eukaryotes: nucleotide sequence and transcriptional analysis of vaccinia virus genes encoding 147-kDa and 22-kDa subunits.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(10):3141-5.
1986: McMichael A J; Michie C A; Gotch F M; Smith G L; Moss B
Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes.
The Journal of general virology 1986;67 ( Pt 4)():719-26.
1986: Chakrabarti S; Robert-Guroff M; Wong-Staal F; Gallo R C; Moss B
Expression of the HTLV-III envelope gene by a recombinant vaccinia virus.
Nature 1986;320(6062):535-7.
1986: Elango N; Prince G A; Murphy B R; Venkatesan S; Chanock R M; Moss B
Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(6):1906-10.
1986: Bennink J R; Yewdell J W; Smith G L; Moss B
Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes.
Journal of virology 1986;57(3):786-91.
1986: Jones L; Ristow S; Yilma T; Moss B
Accidental human vaccination with vaccinia virus expressing nucleoprotein gene.
Nature 1986;319(6054):543.
1986: Stephens E B; Compans R W; Earl P; Moss B
Surface expression of viral glycoproteins is polarized in epithelial cells infected with recombinant vaccinia viral vectors.
The EMBO journal 1986;5(2):237-45.
1986: King C S; Cooper J A; Moss B; Twardzik D R
Vaccinia virus growth factor stimulates tyrosine protein kinase activity of A431 cell epidermal growth factor receptors.
Molecular and cellular biology 1986;6(1):332-6.
1986: Smith G L; Cheng K C; Moss B
Vaccinia virus: an expression vector for genes from parasites.
Parasitology 1986;92 Suppl():S109-17.
1985: Ensinger M J; Weir J P; Moss B
Fine structure marker rescue of temperature-sensitive mutations of vaccinia virus within a central conserved region of the genome.
Journal of virology 1985;56(3):1027-9.
1985: Chakrabarti S; Brechling K; Moss B
Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.
Molecular and cellular biology 1985;5(12):3403-9.
1985: Rosel J; Moss B
Transcriptional and translational mapping and nucleotide sequence analysis of a vaccinia virus gene encoding the precursor of the major core polypeptide 4b.
Journal of virology 1985;56(3):830-8.
1985: Weir J P; Moss B
Use of a bacterial expression vector to identify the gene encoding a major core protein of vaccinia virus.
Journal of virology 1985;56(2):534-40.
1985: Rohrmann G; Moss B
Transcription of vaccinia virus early genes by a template-dependent soluble extract of purified virions.
Journal of virology 1985;56(2):349-55.
1985: Buller R M; Smith G L; Cremer K; Notkins A L; Moss B
Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype.
Nature 1985;317(6040):813-5.
1985: Twardzik D R; Brown J P; Ranchalis J E; Todaro G J; Moss B
Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(16):5300-4.
1985: Cremer K J; Mackett M; Wohlenberg C; Notkins A L; Moss B
Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice.
Science (New York, N.Y.) 1985;228(4700):737-40.
1985: Cochran M A; Puckett C; Moss B
In vitro mutagenesis of the promoter region for a vaccinia virus gene: evidence for tandem early and late regulatory signals.
Journal of virology 1985;54(1):30-7.
1985: Yewdell J W; Bennink J R; Smith G L; Moss B
Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(6):1785-9.
1985: Cochran M A; Mackett M; Moss B
Eukaryotic transient expression system dependent on transcription factors and regulatory DNA sequences of vaccinia virus.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(1):19-23.
1985: Mackett M; Yilma T; Rose J K; Moss B
Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle.
Science (New York, N.Y.) 1985;227(4685):433-5.
1985: Jones E V; Moss B
Transcriptional mapping of the vaccinia virus DNA polymerase gene.
Journal of virology 1985;53(1):312-5.
1985: Winters E; Baroudy B M; Moss B
Molecular cloning of the terminal hairpin of vaccinia virus DNA as an imperfect palindrome in an Escherichia coli plasmid.
Gene 1985;37(1-3):221-8.
1984: Bennink J R; Yewdell J W; Smith G L; Moller C; Moss B
Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells.
Nature 1984;311(5986):578-9.
1984: Moss B; Smith G L; Gerin J L; Purcell R H
Live recombinant vaccinia virus protects chimpanzees against hepatitis B.
Nature 1984;311(5981):67-9.
1984: Weir J P; Moss B
Regulation of expression and nucleotide sequence of a late vaccinia virus gene.
Journal of virology 1984;51(3):662-9.
1984: Smith G L; Godson G N; Nussenzweig V; Nussenzweig R S; Barnwell J; Moss B
Plasmodium knowlesi sporozoite antigen: expression by infectious recombinant vaccinia virus.
Science (New York, N.Y.) 1984;224(4647):397-9.
1984: Mackett M; Smith G L; Moss B
General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.
Journal of virology 1984;49(3):857-64.
1984: Jones E V; Moss B
Mapping of the vaccinia virus DNA polymerase gene by marker rescue and cell-free translation of selected RNA.
Journal of virology 1984;49(1):72-7.
1984: Smith G L; Mackett M; Moss B
Recombinant vaccinia viruses as new live vaccines.
Biotechnology & genetic engineering reviews 1984;2():383-407.
1983: Smith G L; Murphy B R; Moss B
Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(23):7155-9.
1983: Puckett C; Moss B
Selective transcription of vaccinia virus genes in template dependent soluble extracts of infected cells.
Cell 1983;35(2 Pt 1):441-8.
1983: Smith G L; Moss B
Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA.
Gene 1983;25(1):21-8.
1983: Weir J P; Moss B
Nucleotide sequence of the vaccinia virus thymidine kinase gene and the nature of spontaneous frameshift mutations.
Journal of virology 1983;46(2):530-7.
1983: Smith G L; Mackett M; Moss B
Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen.
Nature 1983;302(5908):490-5.
1983: Bajszár G; Wittek R; Weir J P; Moss B
Vaccinia virus thymidine kinase and neighboring genes: mRNAs and polypeptides of wild-type virus and putative nonsense mutants.
Journal of virology 1983;45(1):62-72.
1983: Baroudy B M; Venkatesan S; Moss B
Structure and replication of vaccinia virus telomeres.
Cold Spring Harbor symposia on quantitative biology 1983;47 Pt 2():723-9.
1983: Moss B; Smith G L; Mackett M
Use of vaccinia virus as an infectious molecular cloning and expression vector.
Gene amplification and analysis 1983;3():201-13.
1982: Mackett M; Smith G L; Moss B
Vaccinia virus: a selectable eukaryotic cloning and expression vector.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(23):7415-9.
1982: Venkatesan S; Gershowitz A; Moss B
Complete nucleotide sequences of two adjacent early vaccinia virus genes located within the inverted terminal repetition.
Journal of virology 1982;44(2):637-46.
1982: Baroudy B M; Moss B
Sequence homologies of diverse length tandem repetitions near ends of vaccinia virus genome suggest unequal crossing over.
Nucleic acids research 1982;10(18):5673-9.
1982: Moss B; Cooper N
Genetic evidence for vaccinia virus-encoded DNA polymerase: isolation of phosphonoacetate-resistant enzyme from the cytoplasm of cells infected with mutant virus.
Journal of virology 1982;43(2):673-8.
1982: Wittek R; Moss B
Colinearity of RNAs with the vaccinia virus genome: anomalies with two complementary early and late RNAs result from a small deletion or rearrangement within the inverted terminal repetition.
Journal of virology 1982;42(2):447-55.
1982: Baroudy B M; Venkatesan S; Moss B
Incompletely base-paired flip-flop terminal loops link the two DNA strands of the vaccinia virus genome into one uninterrupted polynucleotide chain.
Cell 1982;28(2):315-24.
1982: Weir J P; Bajszár G; Moss B
Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNA.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(4):1210-4.
1982: Venkatesan S; Moss B
Eukaryotic mRNA capping enzyme-guanylate covalent intermediate.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(2):340-4.
1981: Moss B; Winters E; Cooper J A
Deletion of a 9,000-base-pair segment of the vaccinia virus genome that encodes nonessential polypeptides.
Journal of virology 1981;40(2):387-95.
1981: Langberg S R; Moss B
Post-transcriptional modifications of mRNA. Purification and characterization of cap I and cap II RNA (nucleoside-2'-)-methyltransferases from HeLa cells.
The Journal of biological chemistry 1981;256(19):10054-60.
1981: Venkatesan S; Baroudy B M; Moss B
Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene.
Cell 1981;25(3):805-13.
1981: Cooper J A; Wittek R; Moss B
Extension of the transcriptional and translational map of the left end of the vaccinia virus genome to 21 kilobase pairs.
Journal of virology 1981;39(3):733-45.
1981: Wittek R; Cooper J A; Moss B
Transcriptional and translational mapping of a 6.6-kilobase-pair DNA fragment containing the junction of the terminal repetition and unique sequence at the left end of the vaccinia virus genome.
Journal of virology 1981;39(3):722-32.
1981: Isle H B; Venkatesan S; Moss B
Cell-free translation of early and late mRNAs selected by hybridization to cloned DNA fragments derived from the left 14 million to 72 million daltons of the vaccinia virus genome.
Virology 1981;112(1):306-17.
1981: Moss B; Winters E; Cooper N
Instability and reiteration of DNA sequences within the vaccinia virus genome.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(3):1614-8.
1981: Venkatesan S; Moss B
In vitro transcription of the inverted terminal repetition of the vaccinia virus genome: correspondence of initiation and cap sites.
Journal of virology 1981;37(2):738-47.
1981: Cooper J A; Wittek R; Moss B
Hybridization selection and cell-free translation of mRNA's encoded within the inverted terminal repetition of the vaccinia virus genome.
Journal of virology 1981;37(1):284-94.
1981: Moss B
5' end labeling of RNA with capping and methylating enzymes.
Gene amplification and analysis 1981;2():253-66.
1980: Wittek R; Cooper J A; Barbosa E; Moss B
Expression of the vaccinia virus genome: analysis and mapping of mRNAs encoded within the inverted terminal repetition.
Cell 1980;21(2):487-93.
1980: Wittek R; Moss B
Tandem repeats within the inverted terminal repetition of vaccinia virus DNA.
Cell 1980;21(1):277-84.
1980: Baroudy B M; Moss B
Purification and characterization of a DNA-dependent RNA polymerase from vaccinia virions.
The Journal of biological chemistry 1980;255(9):4372-80.
1980: Keith J M; Winters E M; Moss B
Purification and characterization of a HeLa cell transfer RNA(cytosine-5-)-methyltransferase.
The Journal of biological chemistry 1980;255(10):4636-44.
1980: Wittek R; Barbosa E; Cooper J A; Garon C F; Chan H; Moss B
Inverted terminal repetition in vaccinia virus DNA encodes early mRNAs.
Nature 1980;285(5759):21-5.
1980: Venkatesan S; Moss B
Donor and acceptor specificities of HeLa cell mRNA guanylyltransferase.
The Journal of biological chemistry 1980;255(7):2835-42.
1980: Venkatesan S; Gershowitz A; Moss B
Purification and characterization of mRNA guanylyltransferase from HeLa cell nuclei.
The Journal of biological chemistry 1980;255(7):2829-34.
1980: Venkatesan S; Gershowitz A; Moss B
Modification of the 5' end of mRNA. Association of RNA triphosphatase with the RNA guanylyltransferase-RNA (guanine-7-)methyltransferase complex from vaccinia virus.
The Journal of biological chemistry 1980;255(3):903-8.
1979: Gershowitz A; Moss B
Abortive transcription products of vaccinia virus are guanylylated, methylated, and polyadenylylated.
Journal of virology 1979;31(3):849-53.
1979: Cooper J A; Moss B
Translation of specific vaccinia virus RNAs purified as RNA-DNA hybrids on potassium iodide gradients.
Nucleic acids research 1979;6(11):3599-612.
1979: Cooper J A; Moss B; Katz E
Inhibition of vaccinia virus late protein synthesis by isatin-beta-thiosemicarbazone: characterization and in vitro translation of viral mRNA.
Virology 1979;96(2):381-92.
1979: Cooper J A; Moss B
In vitro translation of immediate early, early, and late classes of RNA from vaccinia virus-infected cells.
Virology 1979;96(2):368-80.
1979: Boone R F; Parr R P; Moss B
Intermolecular duplexes formed from polyadenylylated vaccinia virus RNA.
Journal of virology 1979;30(1):365-74.
1978: Barbosa E; Moss B
mRNA(nucleoside-2'-)-methyltransferase from vaccinia virus. Characteristics and substrate specificity.
The Journal of biological chemistry 1978;253(21):7698-702.
1978: Barbosa E; Moss B
mRNA(nucleoside-2'-)-methyltransferase from vaccinia virus. Purification and physical properties.
The Journal of biological chemistry 1978;253(21):7692-7.
1978: Garon C F; Barbosa E; Moss B
Visualization of an inverted terminal repetition in vaccinia virus DNA.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(10):4863-7.
1978: Gershowitz A; Boone R F; Moss B
Multiple roles for ATP in the synthesis and processing of mRNA by vaccinia virus: specific inhibitory effects of adenosine (beta,gamma-imido) triphosphate.
Journal of virology 1978;27(2):399-408.
1978: Cooper J A; Moss B
Transcription of vaccinia virus mRNA coupled to translation in vitro.
Virology 1978;88(1):149-65.
1978: Keith J M; Muthukrishnan S; Moss B
Effect of methylation of the N6 position of the penultimate adenosine of capped mRNA on ribosome binding.
The Journal of biological chemistry 1978;253(14):5039-41.
1978: Boone R F; Moss B
Sequence complexity and relative abundance of vaccinia virus mRNA's synthesized in vivo and in vitro.
Journal of virology 1978;26(3):554-69.
1978: Muthukrishnan S; Moss B; Cooper J A; Maxwell E S
Influence of 5'-terminal cap structure on the initiation of translation of vaccinia virus mRNA.
The Journal of biological chemistry 1978;253(5):1710-5.
1978: Moss B; Keith J M; Gershowitz A; Ritchey M B; Palese P
Common sequence at the 5' ends of the segmented RNA genomes of influenza A and B viruses.
Journal of virology 1978;25(1):312-8.
1977: Wei C; Moss B
5'-Terminal capping of RNA by guanylyltransferase from HeLa cell nuclei.
Proceedings of the National Academy of Sciences of the United States of America 1977;74(9):3758-61.
1977: Moss B; Gershowitz A; Stringer J R; Holland L E; Wagner E K
5'-Terminal and internal methylated nucleosides in herpes simplex virus type 1 mRNA.
Journal of virology 1977;23(2):234-9.
1977: Boone R F; Moss B
Methylated 5'-terminal sequences of vaccinia virus mRNA species made in vivo at early and late times after infection.
Virology 1977;79(1):67-80.
1977: Wei C M; Moss B
Nucleotide sequences at the N6-methyladenosine sites of HeLa cell messenger ribonucleic acid.
Biochemistry 1977;16(8):1672-6.
1977: Boone R F; Ensinger M J; Moss B
Synthesis of mRNA guanylyltransferase and mRNA methyltransferases in cells infected with vaccinia virus.
Journal of virology 1977;21(2):475-83.
1977: Moss B; Gershowitz A; Weber L A; Baglioni C
Histone mRNAs contain blocked and methylated 5' terminal sequences but lack methylated nucleosides at internal positions.
Cell 1977;10(1):113-20.
1977: Moss B
Utilization of the guanylyltransferase and methyltransferases of vaccinia virus to modify and identify the 5'-terminals of heterologous RNA species.
Biochemical and biophysical research communications 1977;74(2):374-83.
1976: Martin S A; Moss B
mRNA guanylyltransferase and mRNA (guanine-7-)-methyltransferase from vaccinia virions. Donor and acceptor substrate specificites.
The Journal of biological chemistry 1976;251(23):7313-21.
1976: Ensinger M J; Moss B
Modification of the 5' terminus of mRNA by an RNA (guanine-7-)-methyltransferase from HeLa cells.
The Journal of biological chemistry 1976;251(17):5283-91.
1976: Moss B; Gershowitz A; Wei C M; Boone R
Formation of the guanylylated and methylated 5'-terminus of vaccinia virus mRNA.
Virology 1976;72(2):341-51.
1976: Moss B; Koczot F
Sequence of methylated nucleotides at the 5'-terminus of adenovirus-specific RNA.
Journal of virology 1976;17(2):385-92.
1976: Wei C M; Gershowitz A; Moss B
5'-Terminal and internal methylated nucleotide sequences in HeLa cell mRNA.
Biochemistry 1976;15(2):397-401.
1976: Moss B; Martin S A; Ensinger M J; Boone R F; Wei C M
Modification of the 5'-terminals of mRNAs by viral and cellular enzymes.
Progress in nucleic acid research and molecular biology 1976;19():63-81.
1975: Martin S A; Moss B
Modification of RNA by mRNA guanylyltransferase and mRNA (guanine-7-)methyltransferase from vaccinia virions.
The Journal of biological chemistry 1975;250(24):9330-5.
1975: Martin S A; Paoletti E; Moss B
Purification of mRNA guanylyltransferase and mRNA (guanine-7-) methyltransferase from vaccinia virions.
The Journal of biological chemistry 1975;250(24):9322-9.
1975: Wei C; Gershowitz A; Moss B
N6, O2'-dimethyladenosine a novel methylated ribonucleoside next to the 5' terminal of animal cell and virus mRNAs.
Nature 1975;257(5523):251-3.
1975: Rosemond-Hornbeak H; Moss B
Inhibition of host protein synthesis by vaccinia virus: fate of cell mRNA and synthesis of small poly (A)-rich polyribonucleotides in the presence of actinomycin D.
Journal of virology 1975;16(1):34-42.
1975: Ensinger M J; Martin S A; Paoletti E; Moss B
Modification of the 5'-terminus of mRNA by soluble guanylyl and methyl transferases from vaccinia virus.
Proceedings of the National Academy of Sciences of the United States of America 1975;72(7):2525-9.
1975: Moss B; Rosenblum E N; Gershowitz A
Characterization of a polyriboadenylate polymerase from vaccinia virions.
The Journal of biological chemistry 1975;250(12):4722-9.
1975: Kleiman J H; Moss B
Purification of a protein kinase and two phosphate acceptor proteins from vaccinia virions.
The Journal of biological chemistry 1975;250(7):2420-9.
1975: Kleiman J H; Moss B
Characterization of a protein kinase and two phosphate acceptor proteins from vaccinia virions.
The Journal of biological chemistry 1975;250(7):2430-7.
1975: Wei C M; Gershowitz A; Moss B
Methylated nucleotides block 5' terminus of HeLa cell messenger RNA.
Cell 1975;4(4):379-86.
1975: Wei C M; Moss B
Methylated nucleotides block 5'-terminus of vaccinia virus messenger RNA.
Proceedings of the National Academy of Sciences of the United States of America 1975;72(1):318-22.
1974: Paoletti E; Cooper N; Moss B
Regulation of synthesis of two immunologically distinct nucleic acid-dependent nucleoside triphosphate phosphohydrolases in vaccinia virus-infected HeLa cells.
Journal of virology 1974;14(3):578-86.
1974: Wei C M; Moss B
Methylation of newly synthesized viral messenger RNA by an enzyme in vaccinia virus.
Proceedings of the National Academy of Sciences of the United States of America 1974;71(8):3014-8.
1974: Moss B; Rosenblum E N
Vaccinia virus polyriboadenylate polymerase: convalent linkage of the product with polyribonucleotide and polydeoxyribonucleotide primers.
Journal of virology 1974;14(1):86-98.
1974: Rosemond-Hornbeak H; Paoletti E; Moss B
Single-stranded deoxyribonucleic acid-specific nuclease from vaccinia virus. Purification and characterization.
The Journal of biological chemistry 1974;249(10):3287-91.
1974: Rosemond-Hornbeak H; Moss B
Single-stranded deoxyribonucleic acid-specific nuclease from vaccinia virus. Endonucleolytic and exonucleolytic activities.
The Journal of biological chemistry 1974;249(10):3292-6.
1974: Paoletti E; Moss B
Two nucleic acid-dependent nucleoside triphosphate phosphohydrolases from vaccinia virus. Nucleotide substrate and polynucleotide cofactor specificities.
The Journal of biological chemistry 1974;249(10):3281-6.
1974: Paolette E; Rosemond-Hornbeak H; Moss B
Two nucleid acid-dependent nucleoside triphosphate phosphohydrolases from vaccinia virus. Purification and characterization.
The Journal of biological chemistry 1974;249(10):3273-80.
1973: Moss B; Rosenblum E N
Letter: Protein cleavage and poxvirus morphogenesis: tryptic peptide analysis of core precursors accumulated by blocking assembly with rifampicin.
Journal of molecular biology 1973;81(2):267-9.
1973: Kleiman J; Moss B
Protein kinase activity from vaccinia virions: solubilization and separation into heat-labile and heat-stable components.
Journal of virology 1973;12(4):684-9.
1973: Moss B; Rosenblum E N; Garon C F
Glycoprotein synthesis in cells infected with vaccinia virus. 3. Purification and biosynthesis of the virion glycoprotein.
Virology 1973;55(1):143-56.
1973: Moss B; Rosenblum E N; Paoletti E
Polyadenylate polymerase from vaccinia virions.
Nature: New biology 1973;245(141):59-63.
1973: Rosemond H; Moss B
Phosphoprotein component of vaccinia virions.
Journal of virology 1973;11(6):961-70.
1972: Paoletti E; Moss B
Deoxyribonucleic acid-dependent nucleotide phosphohydrolase activity in purified vaccinia virus.
Journal of virology 1972;10(4):866-8.
1972: Paoletti E; Moss B
Protein kinase and specific phosphate acceptor proteins associated with vaccinia virus cores.
Journal of virology 1972;10(3):417-24.
1972: Moss B; Rosenblum E N
Hydroxylapatite chromatography of protein-sodium dodecyl sulfate complexes. A new method for the separation of polypeptide subunits.
The Journal of biological chemistry 1972;247(16):5194-8.
1971: Garon C F; Moss B
Glycoprotein synthesis in cells infected with vaccinia virus. II. A glycoprotein component of the virion.
Virology 1971;46(2):233-46.
1971: Moss B; Rosenblum E N; Garon C F
Glycoprotein synthesis in cells infected with vaccinia virus. I. Non-virion glycoproteins.
Virology 1971;46(2):221-32.
1971: Grimley P M; Moss B
Similar effect of rifampin and other rifamycin derivatives on vaccinia virus morphogenesis.
Journal of virology 1971;8(2):225-31.
1971: Moss B; Rosenblum E N; Grimley P M
Assembly of virus particles during mixed infection with wild-type vaccinia and a rifampicin-resistant mutant.
Virology 1971;45(1):135-48.
1971: Moss B; Rosenblum E N; Grimley P M
Assembly of vaccinia virus particles from polypeptides made in the presence of rifampicin.
Virology 1971;45(1):123-34.
1970: Katz E; Moss B
Vaccinia virus structural polypeptide derived from a high-molecular-weight precursor: formation and integration into virus particles.
Journal of virology 1970;6(6):717-26.
1970: Grimley P M; Rosenblum E N; Mims S J; Moss B
Interruption by Rifampin of an early stage in vaccinia virus morphogenesis: accumulation of membranes which are precursors of virus envelopes.
Journal of virology 1970;6(4):519-33.
1970: Katz E; Grimley P; Moss B
Reversal of anti-viral effects of rifampicin.
Nature 1970;227(5262):1050-1.
1970: Katz E; Moss B
Formation of a vaccinia virus structural polypeptide from a higher molecular weight precursor: inhibition by rifampicin.
Proceedings of the National Academy of Sciences of the United States of America 1970;66(3):677-84.
1969: Moss B; Rosenblum E N; Katz E; Grimley P M
Rifampicin: a specific inhibitor of vaccinia virus assembly.
Nature 1969;224(5226):1280-4.
1969: Moss B; Katz E
Synthesis of vaccinia viral proteins in cytoplasmic extracts. II. Identification of early and late viral proteins.
Journal of virology 1969;4(5):596-602.
1969: Katz E; Moss B
Synthesis of vaccinia viral proteins in cytoplasmic extracts. I. Incorporation of radioactively labeled amino acids into polypeptides.
Journal of virology 1969;4(4):416-22.
1969: Moss B; Katz E; Rosenblum E N
Vaccinia virus directed RNA and protein synthesis in the presence of rifampicin.
Biochemical and biophysical research communications 1969;36(5):858-65.
1968: Moss B
Inhibition of HeLa cell protein synthesis by the vaccinia virion.
Journal of virology 1968;2(10):1028-37.
1968: Moss B; Salzman N P
Sequential protein synthesis following vaccinia virus infection.
Journal of virology 1968;2(10):1016-27.

Sign-in to see more